KDR
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Y Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1065 | Sugiyama | POTEF A26C1B | ILASLSTFQQMWISKQEyDEsGPsIVHRKCL__________ |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A5A3E0 | Y1062 | Sugiyama | POTEF A26C1B | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCL_______ |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A6NMY6 | S161 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | QEINRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAE |
| A6NMY6 | S164 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | NRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDGS |
| A6NMY6 | Y333 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | KsLyyyIQQDTKGDyQKALLyLCGGDD______________ |
| A8K0Z3 | Y103 | Sugiyama | WASHC1 FAM39E WASH1 | KKAIKVFSSAKYPAPGRLQEyGsIFTGAQDPGLQRRPRHRI |
| C4AMC7 | Y103 | Sugiyama | WASH3P FAM39DP | KKAIKVFSSAKYPAPERLQEyGsIFTGAQDPGLQRRPRHRI |
| O00116 | Y645 | Sugiyama | AGPS AAG5 | QWLKESIsDVGFGMLKSVKEyVDPNNIFGNRNLL_______ |
| O00170 | Y202 | Sugiyama | AIP XAP2 | IHQEGNRLYREGHVKEAAAKyyDAIACLKNLQMKEQPGSPE |
| O00170 | Y203 | Sugiyama | AIP XAP2 | HQEGNRLYREGHVKEAAAKyyDAIACLKNLQMKEQPGSPEW |
| O00193 | Y84 | Sugiyama | SMAP C11orf58 | TSHFRTGEEDKKINEELEsQyQQsMDsKLSGRYRRHCGLGF |
| O00299 | Y233 | Sugiyama | CLIC1 G6 NCC27 | AyAREEFAstCPDDEEIELAyEQVAKALK____________ |
| O00469 | Y444 | Sugiyama | PLOD2 | LWSNFWGALSPDGYYARsEDyVDIVQGNRVGVWNVPYMANV |
| O00469 | Y586 | Sugiyama | PLOD2 | FWFPIFSEKACDELVEEMEHyGKWSGGKHHDsRIsGGyENV |
| O00625 | Y131 | Sugiyama | PIR | AHGLQLWVNLRSSEKMVEPQyQELKSEEIPKPSKDGVTVAV |
| O14602 | Y35 | Sugiyama | EIF1AY | GKNENESEKRELVFKEDGQEyAQVIKMLGNGRLEALCFDGV |
| O14818 | Y106 | Sugiyama | PSMA7 HSPC | RARVECQsHRLTVEDPVTVEyITRYIASLKQRYTQSNGRRP |
| O14818 | Y145 | Sugiyama | PSMA7 HSPC | RPFGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGA |
| O14818 | Y153 | Sugiyama | PSMA7 HSPC | IVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFLE |
| O14818 | Y176 | Sugiyama | PSMA7 HSPC | WKANAIGRGAKSVREFLEKNyTDEAIETDDLTIKLVIKALL |
| O14910 | Y133 | Sugiyama | LIN7A MALS1 VELI1 | KTDEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLKRGD |
| O14950 | Y143 | Sugiyama | MYL12B MRLC2 MYLC2B | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| O14950 | Y156 | Sugiyama | MYL12B MRLC2 MYLC2B | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| O14974 | Y911 | Sugiyama | PPP1R12A MBS MYPT1 | ETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDSTD |
| O14979 | Y167 | Sugiyama | HNRNPDL HNRPDL JKTBP | DGKMFIGGLSWDTsKKDLtEyLSRFGEVVDCtIKTDPVTGR |
| O15230 | Y81 | Sugiyama | LAMA5 KIAA0533 KIAA1907 | SATCGEEAPARGSPRPTEDLyCKLVGGPVAGGDPNQTIRGQ |
| O15234 | Y240 | Sugiyama | CASC3 MLN51 | HDKFREDEQAPKSRQELIALyGyDIRSAHNPDDIKPRRIRK |
| O15234 | Y242 | Sugiyama | CASC3 MLN51 | KFREDEQAPKSRQELIALyGyDIRSAHNPDDIKPRRIRKPR |
| O15371 | T46 | Sugiyama | EIF3D EIF3S7 | RDMPyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGG |
| O15371 | Y201 | Sugiyama | EIF3D EIF3S7 | KMRyLEVSEPQDIECCGALEyyDKAFDRITTRSEKPLRSIK |
| O15371 | Y202 | Sugiyama | EIF3D EIF3S7 | MRyLEVSEPQDIECCGALEyyDKAFDRITTRSEKPLRSIKR |
| O15371 | Y30 | Sugiyama | EIF3D EIF3S7 | QDNPSGWGPCAVPEQFRDMPyQPFsKGDRLGKVADWtGAty |
| O15371 | Y50 | Sugiyama | EIF3D EIF3S7 | yQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQYA |
| O43164 | Y63 | Sugiyama | PJA2 KIAA0438 RNF131 | VSFKPCMTRHERSLGRAGDDyEVLELDDVPKENssGssPLD |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43390 | Y434 | Sugiyama | HNRNPR HNRPR | KKRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGG |
| O43390 | Y435 | Sugiyama | HNRNPR HNRPR | KRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGR |
| O43390 | Y436 | Sugiyama | HNRNPR HNRPR | RKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGRG |
| O43448 | Y311 | Sugiyama | KCNAB3 KCNA3B | LITSKYDGRVPDTCRASIKGyQWLKDKVQSEDGKKQQAKVM |
| O43707 | Y397 | Sugiyama | ACTN4 | GKMVSDINNGWQHLEQAEKGyEEWLLNEIRRLERLDHLAEK |
| O43707 | Y441 | Sugiyama | ACTN4 | KAsIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEs |
| O43707 | Y878 | Sugiyama | ACTN4 | DKNFITAEELRRELPPDQAEyCIARMAPyQGPDAVPGALDy |
| O43765 | Y195 | Sugiyama | SGTA SGT SGT1 | HVEAVAYYKKALELDPDNEtyKsNLKIAELKLREAPSPTGG |
| O43823 | Y311 | Sugiyama | AKAP8 AKAP95 | RGFDRFGPDGTGRKRKQFQLyEEPDtKLARVDsEGDFsEND |
| O43852 | S219 | Sugiyama | CALU | DIDKNADGFIDLEEyIGDMysHDGNtDEPEWVKTEREQFVE |
| O43852 | S44 | Sugiyama | CALU | KKDRVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQL |
| O43852 | Y106 | Sugiyama | CALU | GFVtVDELKDWIKFAQKRWIyEDVERQWKGHDLNEDGLVsW |
| O43852 | Y129 | Sugiyama | CALU | VERQWKGHDLNEDGLVsWEEyKNATYGYVLDDPDPDDGFNY |
| O43852 | Y185 | Sugiyama | CALU | KDGDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNAD |
| O43852 | Y187 | Sugiyama | CALU | GDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNADGF |
| O43852 | Y213 | Sugiyama | CALU | VQEtMEDIDKNADGFIDLEEyIGDMysHDGNtDEPEWVKTE |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O43852 | Y47 | Sugiyama | CALU | RVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQLtPE |
| O60488 | Y582 | Sugiyama | ACSL4 ACS4 FACL4 LACS4 | DGCLQIIDRKKDLVKLQAGEyVsLGKVEAALKNCPLIDNIC |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O60716 | Y228 | Sugiyama | CTNND1 KIAA0384 | yPPDGysRHyEDGyPGGsDNyGsLsRVtRIEERyRPsMEGy |
| O60739 | Y30 | Sugiyama | EIF1B | FDPFADATKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| O60814 | Y41 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| O60814 | Y43 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| O60841 | S183 | Sugiyama | EIF5B IF2 KIAA0741 | GsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKN |
| O75116 | Y936 | Sugiyama | ROCK2 KIAA0619 | EITLTKADSEQLARsIAEEQysDLEKEKIMKELEIKEMMAR |
| O75131 | Y162 | Sugiyama | CPNE3 CPN3 KIAA0636 | LFEMEARKLDNKDLFGKSDPyLEFHKQTSDGNWLMVHRTEV |
| O75208 | Y93 | Sugiyama | COQ9 C16orf49 HSPC326 PSEC0129 | PEssHsPPRYTDQGGEEEEDyEsEEQLQHRILTAALEFVPA |
| O75223 | T169 | Sugiyama | GGCT C7orf24 CRF21 | ENGLPLEyQEKLKAIEPNDytGKVsEEIEDIIKKGETQTL_ |
| O75223 | Y168 | Sugiyama | GGCT C7orf24 CRF21 | KENGLPLEyQEKLKAIEPNDytGKVsEEIEDIIKKGETQTL |
| O75347 | Y75 | Sugiyama | TBCA | EILQEsRMMIPDCQRRLEAAyLDLQRILENEKDLEEAEEyK |
| O75347 | Y94 | Sugiyama | TBCA | AyLDLQRILENEKDLEEAEEyKEARLVLDsVKLEA______ |
| O75348 | Y47 | Sugiyama | ATP6V1G1 ATP6G ATP6G1 ATP6J | KRKNRRLKQAKEEAQAEIEQyRLQREKEFKAKEAAALGsRG |
| O75369 | Y902 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | VQFNsPLPGDAVKDLDIIDNyDysHtVKYtPtQQGNMQVLV |
| O75688 | Y367 | Sugiyama | PPM1B PP2CB | IPNLPPGGGLAGKRNVIEAVySRLNPHREsDGAsDEAEEsG |
| O75874 | Y391 | Sugiyama | IDH1 PICD | FMTKDLAACIKGLPNVQRsDyLNTFEFMDKLGENLKIKLAQ |
| O75886 | Y291 | Sugiyama | STAM2 HBP | KLNVIDDDVEEIKKSEPEPVyIDEDKMDRALQVLQSIDPTD |
| O94906 | Y105 | Sugiyama | PRPF6 C20orf14 | AGSLFSSGPYEKDDEEADAIyAALDKRMDERRKERREQREK |
| O94919 | Y139 | Sugiyama | ENDOD1 KIAA0830 | TSVNSLGSKQALNtDyLDsDyQRGQLYPFSLSSDVQVATFT |
| O94992 | Y291 | Sugiyama | HEXIM1 CLP1 EDG1 HIS1 MAQ1 | yERyHTEsLQNMsKQELIKEyLELEKCLsRMEDENNRLRLE |
| O95218 | S120 | Sugiyama | ZRANB2 ZIS ZNF265 | tGYGGGFNERENVEyIEREEsDGEyDEFGRKKKKYRGKAVG |
| O95218 | Y114 | Sugiyama | ZRANB2 ZIS ZNF265 | AKLEERtGYGGGFNERENVEyIEREEsDGEyDEFGRKKKKY |
| O95218 | Y124 | Sugiyama | ZRANB2 ZIS ZNF265 | GGFNERENVEyIEREEsDGEyDEFGRKKKKYRGKAVGPAsI |
| O95218 | Y167 | Sugiyama | ZRANB2 ZIS ZNF265 | EVEDKEsEGEEEDEDEDLsKyKLDEDEDEDDADLsKyNLDA |
| O95573 | Y591 | Sugiyama | ACSL3 ACS3 FACL3 LACS3 | DGCLKIIDRKKDLVKLQAGEyVsLGKVEAALKNLPLVDNIC |
| O95707 | T62 | Sugiyama | POP4 RPP29 | MsPQAREDQLQRKAVVLEyFtRHKRKEKKKKAKGLSARQRR |
| O95757 | Y627 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | MIMQDKLEKERNDAKNAVEEyVyDFRDRLGtVYEKFITPED |
| O95757 | Y629 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | MQDKLEKERNDAKNAVEEyVyDFRDRLGtVYEKFITPEDLS |
| O95817 | Y247 | Sugiyama | BAG3 BIS | QAQKTHyPAQQGEyQtHQPVyHKIQGDDWEPRPLRAAsPFR |
| O95926 | Y210 | Sugiyama | SYF2 CBPIN GCIPIP | IEKRDKYSRRRPYNDDADIDyINERNAKFNKKAERFYGKYT |
| O96019 | Y69 | Sugiyama | ACTL6A BAF53 BAF53A INO80K | DGsTLMEIDGDKGKQGGPtyyIDtNALRVPRENMEAIsPLK |
| P00338 | Y172 | Sugiyama | LDHA PIG19 | GFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHGWVLGE |
| P00338 | Y239 | Sugiyama | LDHA PIG19 | GtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVADL |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P00966 | Y163 | Sugiyama | ASS1 ASS | APWRMPEFYNRFKGRNDLMEyAKQHGIPIPVtPKNPWSMDE |
| P02786 | Y152 | Sugiyama | TFRC | sEKLDstDFTGtIKLLNENsyVPREAGsQKDENLALyVENQ |
| P04080 | Y97 | Sugiyama | CSTB CST6 STFB | NKPLtLsNyQTNKAKHDELtyF___________________ |
| P04181 | Y48 | Sugiyama | OAT | VATKKtVQGPPtSDDIFEREyKyGAHNyHPLPVALERGKGI |
| P04181 | Y55 | Sugiyama | OAT | QGPPtSDDIFEREyKyGAHNyHPLPVALERGKGIyLWDVEG |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04792 | Y23 | Sugiyama | HSPB1 HSP27 HSP28 | ERRVPFsLLRGPsWDPFRDWyPHsRLFDQAFGLPRLPEEWS |
| P04920 | Y73 | Sugiyama | SLC4A2 AE2 EPB3L1 HKB3 MPB3L | EAGsRGGEEPGRsYGEEDFEyHRQSSHHIHHPLSTHLPPDA |
| P05067 | Y308 | Sugiyama | APP A4 AD1 | REVCSEQAETGPCRAMISRWyFDVTEGKCAPFFyGGCGGNR |
| P05198 | Y142 | Sugiyama | EIF2S1 EIF2A | TKDEQLEsLFQRTAWVFDDKyKRPGyGAyDAFKHAVsDPsI |
| P05198 | Y147 | Sugiyama | EIF2S1 EIF2A | LEsLFQRTAWVFDDKyKRPGyGAyDAFKHAVsDPsILDsLD |
| P05198 | Y150 | Sugiyama | EIF2S1 EIF2A | LFQRTAWVFDDKyKRPGyGAyDAFKHAVsDPsILDsLDLNE |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05388 | Y13 | Sugiyama | RPLP0 | ________MPREDRATWKSNyFLKIIQLLDDyPKCFIVGAD |
| P05388 | Y24 | Sugiyama | RPLP0 | EDRATWKSNyFLKIIQLLDDyPKCFIVGADNVGsKQMQQIR |
| P05455 | Y104 | Sugiyama | SSB | EDKTKIRRsPsKPLPEVTDEyKNDVKNRsVYIKGFPtDAtL |
| P05787 | Y204 | Sugiyama | KRT8 CYK8 | NKRTEMENEFVLIKKDVDEAyMNKVELESRLEGLTDEINFL |
| P06493 | Y15 | Sugiyama | CDK1 CDC2 CDC28A CDKN1 P34CDC2 | ______MEDyTKIEKIGEGtyGVVyKGRHKTTGQVVAMKKI |
| P06733 | S268 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | ASEFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyP |
| P06733 | S272 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | FRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsI |
| P06733 | S291 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IsPDQLADLyKsFIKDyPVVsIEDPFDQDDWGAWQKFtAsA |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | Y189 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | MILPVGAANFREAMRIGAEVyHNLKNVIKEKyGKDAtNVGD |
| P06733 | Y200 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EAMRIGAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILEN |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y287 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | PsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDDWGAWQKF |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06899 | Y41 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P06899 | Y43 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07237 | Y99 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | LAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPKEytAG |
| P07355 | S161 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | QEINRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAE |
| P07355 | S164 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | NRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDGs |
| P07355 | Y188 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVKRKGT |
| P07355 | Y199 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RAEDGsVIDyELIDQDARDLyDAGVKRKGTDVPKWIsIMTE |
| P07355 | Y333 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | KsLyyyIQQDTKGDyQKALLyLCGGDD______________ |
| P07384 | Y42 | Sugiyama | CAPN1 CANPL1 PIG30 | RARELGLGRHENAIKyLGQDyEQLRVRCLQSGTLFRDEAFP |
| P07437 | T107 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKEAESC |
| P07437 | T35 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | QIGAKFWEVISDEHGIDPTGtyHGDsDLQLDRIsVyyNEAt |
| P07437 | Y106 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | RPDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKEAES |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07437 | Y51 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | DPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPG |
| P07737 | Y129 | EPSD|PSP|Sugiyama | PFN1 | tLVLLMGKEGVHGGLINKKCyEMAsHLRRsQY_________ |
| P07814 | Y827 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EIGQNIssNssAsILESKsLyDEVAAQGEVVRKLKAEKSPK |
| P07900 | T65 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPNKQ |
| P07900 | Y197 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | GEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIGyP |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P07900 | Y492 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLR |
| P07900 | Y493 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLRK |
| P07900 | Y61 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KEIFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLI |
| P07900 | Y627 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | TANMERIMKAQALRDNstMGyMAAKKHLEINPDHsIIEtLR |
| P07954 | Y110 | Sugiyama | FH | tPVIKAFGILKRAAAEVNQDyGLDPKIANAIMKAADEVAEG |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | T297 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IDQEELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLA |
| P08238 | T60 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPNPQ |
| P08238 | Y192 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y430 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KKCLELFsELAEDKENyKKFyEAFSKNLKLGIHEDstNRRR |
| P08238 | Y472 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKE |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08238 | Y485 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRK |
| P08238 | Y56 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEIFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDII |
| P08238 | Y619 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | TANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVEtLR |
| P08708 | S89 | Sugiyama | RPS17 RPS17L | ISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKEMLKLL |
| P08708 | Y84 | Sugiyama | RPS17 RPS17L | GPVRGISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKE |
| P08758 | Y133 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | IIAsRtPEELRAIKQVyEEEyGssLEDDVVGDTSGYYQRML |
| P09104 | T41 | Sugiyama | ENO2 | EVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKG |
| P09234 | Y12 | Sugiyama | SNRPC | _________MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHKE |
| P09234 | Y8 | Sugiyama | SNRPC | _____________MPKFyCDyCDtyLtHDsPsVRKTHCSGR |
| P09651 | Y341 | Sugiyama | HNRNPA1 HNRPA1 | QSSNFGPMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGss |
| P09651 | Y347 | Sugiyama | HNRNPA1 HNRPA1 | PMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGssssssyG |
| P0CG38 | S1065 | Sugiyama | POTEI | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P0CG38 | Y1062 | Sugiyama | POTEI | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG39 | S1028 | Sugiyama | POTEJ | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P0CG39 | Y1025 | Sugiyama | POTEJ | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0DPH7 | T94 | Sugiyama | TUBA3C TUBA2 | VVDEVRtGtyRQLFHPEQLItGKEDAANNyARGHYTIGKEI |
| P0DPH7 | Y103 | Sugiyama | TUBA3C TUBA2 | yRQLFHPEQLItGKEDAANNyARGHYTIGKEIVDLVLDRIR |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T37 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P11142 | T38 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11413 | Y118 | Sugiyama | G6PD | LEDFFARNsyVAGQyDDAAsyQRLNsHMNALHLGsQANRLF |
| P11940 | Y194 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLFGKF |
| P11940 | Y382 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | PLyVALAQRKEERQAHLtNQyMQRMASVRAVPNPVINPYQP |
| P12268 | Y509 | Sugiyama | IMPDH2 IMPD2 | KFEKRtssAQVEGGVHsLHsyEKRLF_______________ |
| P12277 | Y125 | Sugiyama | CKB CKBB | EHKTDLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPH |
| P12277 | Y39 | Sugiyama | CKB CKBB | EFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDDVIQT |
| P12814 | Y378 | Sugiyama | ACTN1 | GRMVSDINNAWGCLEQVEKGyEEWLLNEIRRLERLDHLAEK |
| P12814 | Y859 | Sugiyama | ACTN1 | DKNyITMDELRRELPPDQAEyCIARMAPYTGPDSVPGALDY |
| P13639 | Y367 | Sugiyama | EEF2 EF2 | GDALLQMITIHLPSPVTAQKyRCELLyEGPPDDEAAMGIKs |
| P13639 | Y373 | Sugiyama | EEF2 EF2 | MITIHLPSPVTAQKyRCELLyEGPPDDEAAMGIKsCDPKGP |
| P13639 | Y579 | Sugiyama | EEF2 EF2 | KDLEEDHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKH |
| P13639 | Y634 | Sugiyama | EEF2 EF2 | AEDIDKGEVsARQELKQRARyLAEKyEWDVAEARKIWCFGP |
| P13639 | Y639 | Sugiyama | EEF2 EF2 | KGEVsARQELKQRARyLAEKyEWDVAEARKIWCFGPDGTGP |
| P13639 | Y671 | Sugiyama | EEF2 EF2 | CFGPDGTGPNILTDITKGVQyLNEIKDSVVAGFQWATKEGA |
| P13639 | Y730 | Sugiyama | EEF2 EF2 | HADAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQ |
| P13667 | Y137 | Sugiyama | PDIA4 ERP70 ERP72 | VAKIDAtsAsVLAsRFDVsGyPtIKILKKGQAVDyEGsRtQ |
| P13667 | Y273 | Sugiyama | PDIA4 ERP70 ERP72 | PTLKIFRKGRPYDYNGPREKyGIVDyMIEQSGPPSKEILTL |
| P13667 | Y278 | Sugiyama | PDIA4 ERP70 ERP72 | FRKGRPYDYNGPREKyGIVDyMIEQSGPPSKEILTLKQVQE |
| P13667 | Y458 | Sugiyama | PDIA4 ERP70 ERP72 | VLEVAKDFPEytFAIADEEDyAGEVKDLGLsEsGEDVNAAI |
| P13674 | Y141 | Sugiyama | P4HA1 P4HA | FPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSF |
| P13674 | Y282 | Sugiyama | P4HA1 P4HA | ASDDQSDQKTTPKKKGVAVDyLPERQKyEMLCRGEGIKMTP |
| P13693 | Y18 | Sugiyama | TPT1 | ___MIIYRDLIsHDEMFsDIyKIREIADGLCLEVEGKMVSR |
| P13929 | T41 | Sugiyama | ENO3 | EVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKG |
| P13929 | Y189 | Sugiyama | ENO3 | MILPVGAsSFKEAMRIGAEVyHHLKGVIKAKYGKDATNVGD |
| P14324 | Y349 | Sugiyama | FDPS FPS KIAA1293 | QDNKCSWLVVQCLQRATPEQyQILKENYGQKEAEKVARVKA |
| P14618 | Y83 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | EMIKsGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAsDPI |
| P14625 | S523 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | RtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAG |
| P14625 | Y258 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GNTLGRGTTITLVLKEEAsDyLELDTIKNLVKKYSQFINFP |
| P14625 | Y401 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | VTFKSILFVPTSAPRGLFDEyGsKKSDYIKLYVRRVFITDD |
| P14625 | Y429 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IKLYVRRVFITDDFHDMMPKyLNFVKGVVDsDDLPLNVsRE |
| P14625 | Y527 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | AKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAGsSRK |
| P14625 | Y539 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDItsLDQyVERMKEKQDKIyFMAGsSRKEAEssPFVERLL |
| P14649 | S87 | Sugiyama | MYL6B MLC1SA | EEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVLK |
| P14649 | Y86 | Sugiyama | MYL6B MLC1SA | LEEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVL |
| P14854 | Y57 | Sugiyama | COX6B1 COX6B | FHRCQKAMTAKGGDIsVCEWyQRVYQsLCPtsWVTDWDEQR |
| P15311 | Y191 | Sugiyama | EZR VIL2 | RIQVWHAEHRGMLKDNAMLEyLKIAQDLEMYGINYFEIKNK |
| P15311 | Y424 | Sugiyama | EZR VIL2 | ERQAVDQIKsQEQLAAELAEytAKIALLEEARRRKEDEVEE |
| P15328 | Y80 | Sugiyama | FOLR1 FOLR | WRKNACCSTNTSQEAHKDVsyLyRFNWNHCGEMAPACKRHF |
| P15880 | S225 | Sugiyama | RPS2 RPS4 | VsAPVPKKLLMMAGIDDCytsARGCtAtLGNFAKATFDAIS |
| P15880 | T224 | Sugiyama | RPS2 RPS4 | IVsAPVPKKLLMMAGIDDCytsARGCtAtLGNFAKATFDAI |
| P15880 | Y266 | Sugiyama | RPS2 RPS4 | KTysyLtPDLWKEtVFtKsPyQEFtDHLVKtHtRVsVQRtQ |
| P15924 | Y56 | Sugiyama | DSP | GtsRMYYSRRGVITDQNsDGyCQtGtMsRHQNQNTIQELLQ |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P17812 | Y473 | Sugiyama | CTPS1 CTPS | RRtLFQTKNsVMRKLyGDADyLEERHRHRFEVNPVWKKCLE |
| P17844 | Y59 | Sugiyama | DDX5 G17P1 HELR HLR1 | EKLVKKKWNLDELPKFEKNFyQEHPDLARRtAQEVETYRRS |
| P17980 | Y185 | Sugiyama | PSMC3 TBP1 | PtEyDsRVKAMEVDERPtEQysDIGGLDKQIQELVEAIVLP |
| P17980 | Y381 | Sugiyama | PSMC3 TBP1 | ARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQCKAVCV |
| P17987 | Y545 | Sugiyama | TCP1 CCT1 CCTA | LRIDDLIKLHPESKDDKHGsyEDAVHsGALND_________ |
| P18124 | Y155 | Sugiyama | RPL7 | IVEPYIAWGYPNLKsVNELIyKRGYGKINKKRIALtDNALI |
| P18124 | Y82 | Sugiyama | RPL7 | RQMYRTEIRMARMARKAGNFyVPAEPKLAFVIRIRGINGVS |
| P18206 | Y822 | Sugiyama | VCL | KAVAGNIsDPGLQKsFLDsGyRILGAVAKVREAFQPQEPDF |
| P18615 | Y133 | Sugiyama | NELFE RD RDBP | sIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEA |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18621 | Y4 | Sugiyama | RPL17 | _________________MVRysLDPENPtKsCKSRGSNLRV |
| P18669 | S134 | Sugiyama | PGAM1 PGAMA CDABP0006 | IWRRsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsCE |
| P18669 | Y119 | Sugiyama | PGAM1 PGAMA CDABP0006 | NKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsKD |
| P18669 | Y133 | Sugiyama | PGAM1 PGAMA CDABP0006 | KIWRRsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsC |
| P18669 | Y142 | Sugiyama | PGAM1 PGAMA CDABP0006 | PPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIAR |
| P18669 | Y26 | Sugiyama | PGAM1 PGAMA CDABP0006 | LVLIRHGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALR |
| P19105 | Y142 | Sugiyama | MYL12A MLCB MRLC3 RLC | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| P19105 | Y155 | Sugiyama | MYL12A MLCB MRLC3 RLC | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| P19338 | T464 | Sugiyama | NCL | KTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWsGE |
| P19338 | Y351 | Sugiyama | NCL | FAKNDLAVVDVRIGMTRKFGyVDFEsAEDLEKALELtGLKV |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P19338 | Y463 | Sugiyama | NCL | EKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWsG |
| P20042 | Y174 | Sugiyama | EIF2S2 EIF2B | DDGIsFsNQtGPAWAGSERDytyEELLNRVFNIMREKNPDM |
| P20618 | Y150 | Sugiyama | PSMB1 PSC5 | FPYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSAS |
| P20618 | Y158 | Sugiyama | PSMB1 PSC5 | IGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLD |
| P20810 | Y339 | Sugiyama | CAST | KAKEEKLEKCGEDDEtIPsEyRLKPATDKDGKPLLPEPEEK |
| P21980 | T368 | Sugiyama | TGM2 | QPGYEGWQALDPTPQEKsEGtyCCGPVPVRAIKEGDLstKy |
| P21980 | Y369 | Sugiyama | TGM2 | PGYEGWQALDPTPQEKsEGtyCCGPVPVRAIKEGDLstKyD |
| P22234 | Y22 | Sugiyama | PAICS ADE2 AIRC PAIS | AtAEVLNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAG |
| P22314 | Y55 | Sugiyama | UBA1 A1S9T UBE1 | SVPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSV |
| P22314 | Y666 | Sugiyama | UBA1 A1S9T UBE1 | QWARDEFEGLFKQPAENVNQyLtDPKFVERtLRLAGtQPLE |
| P23246 | Y488 | Sugiyama | SFPQ PSF | PMYQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQV |
| P23246 | Y490 | Sugiyama | SFPQ PSF | YQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQVEK |
| P23284 | Y47 | Sugiyama | PPIB CYPB | LPGPSAADEKKKGPKVTVKVyFDLRIGDEDVGRVIFGLFGK |
| P23396 | S35 | Sugiyama | RPS3 OK/SW-cl.26 | GIFKAELNEFLtRELAEDGysGVEVRVtPTRTEIIILATRT |
| P23396 | Y34 | Sugiyama | RPS3 OK/SW-cl.26 | DGIFKAELNEFLtRELAEDGysGVEVRVtPTRTEIIILATR |
| P23434 | Y139 | Sugiyama | GCSH | EVTEINEALAENPGLVNKSCyEDGWLIKMtLsNPsELDELM |
| P23434 | Y164 | Sugiyama | GCSH | LIKMtLsNPsELDELMsEEAyEKYIKSIEE___________ |
| P23526 | Y193 | Sugiyama | AHCY SAHH | LKVPAINVNDsVtKsKFDNLyGCRESLIDGIKRATDVMIAG |
| P23527 | Y41 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P23527 | Y43 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P23528 | Y68 | Sugiyama | CFL1 CFL | ILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAt |
| P23588 | Y211 | Sugiyama | EIF4B | DsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDRYDsD |
| P23588 | Y609 | Sugiyama | EIF4B | sASKyAALsVDGEDENEGEDyAE__________________ |
| P24534 | Y18 | Sugiyama | EEF1B2 EEF1B EF1B | ___MGFGDLKsPAGLQVLNDyLADKSYIEGYVPsQADVAVF |
| P24752 | Y214 | Sugiyama | ACAT1 ACAT MAT | GsCAENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNE |
| P24752 | Y256 | Sugiyama | ACAT1 ACAT MAT | IPVtVtVKGQPDVVVKEDEEyKRVDFSKVPKLKTVFQKENG |
| P24752 | Y90 | Sugiyama | ACAT1 ACAT MAT | IAIQGAIEKAGIPKEEVKEAyMGNVLQGGEGQAPTRQAVLG |
| P24941 | Y15 | Sugiyama | CDK2 CDKN2 | ______MENFQKVEKIGEGtyGVVyKARNKLTGEVVALKKI |
| P25205 | Y19 | Sugiyama | MCM3 | __MAGtVVLDDVELREAQRDyLDFLDDEEDQGIyQsKVREL |
| P25205 | Y32 | Sugiyama | MCM3 | LREAQRDyLDFLDDEEDQGIyQsKVRELIsDNQyRLIVNVN |
| P25205 | Y45 | Sugiyama | MCM3 | DEEDQGIyQsKVRELIsDNQyRLIVNVNDLRRKNEKRANRL |
| P25205 | Y456 | Sugiyama | MCM3 | AGIHARLNARCsVLAAANPVyGRyDQyKTPMENIGLQDSLL |
| P25205 | Y459 | Sugiyama | MCM3 | HARLNARCsVLAAANPVyGRyDQyKTPMENIGLQDSLLSRF |
| P25205 | Y462 | Sugiyama | MCM3 | LNARCsVLAAANPVyGRyDQyKTPMENIGLQDSLLSRFDLL |
| P25398 | Y127 | Sugiyama | RPS12 | sCVVVKDYGKESQAKDVIEEyFKCKK_______________ |
| P25685 | Y5 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | ________________MGKDyyQTLGLARGAsDEEIKRAYR |
| P25685 | Y52 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | HPDKNKEPGAEEKFKEIAEAyDVLSDPRKREIFDRYGEEGL |
| P25685 | Y6 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | _______________MGKDyyQTLGLARGAsDEEIKRAYRR |
| P25786 | T11 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | __________MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQ |
| P25786 | Y6 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______________MFRNQyDNDVtVWsPQGRIHQIEYAM |
| P25789 | S7 | Sugiyama | PSMA4 HC9 PSC9 | ______________MSRRyDsRttIFsPEGRLYQVEYAMEA |
| P25789 | Y5 | Sugiyama | PSMA4 HC9 PSC9 | ________________MSRRyDsRttIFsPEGRLYQVEYAM |
| P26196 | Y469 | Sugiyama | DDX6 HLR2 RCK | IEEQLGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP______ |
| P26196 | Y473 | Sugiyama | DDX6 HLR2 RCK | LGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP__________ |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26599 | Y127 | Sugiyama | PTBP1 PTB | ANTMVNYYTSVTPVLRGQPIyIQFsNHKELKtDSSPNQARA |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27348 | Y118 | Sugiyama | YWHAQ | LELLDKYLIANATNPESKVFyLKMKGDYFRyLAEVACGDDR |
| P27348 | Y149 | Sugiyama | YWHAQ | LAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLG |
| P27348 | Y48 | Sugiyama | YWHAQ | AVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSIEQK |
| P27695 | Y128 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | LQELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGD |
| P27695 | Y45 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | KSKTAAKKNDKEAAGEGPALyEDPPDQKtsPsGKPAtLKIC |
| P27824 | Y70 | Sugiyama | CANX | TAPPSSPKVTYKAPVPtGEVyFADsFDRGTLSGWILSKAKK |
| P28066 | Y185 | Sugiyama | PSMA5 | CDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSLIILKQV |
| P28066 | Y8 | Sugiyama | PSMA5 | _____________MFLTRsEyDRGVNtFsPEGRLFQVEyAI |
| P29353 | Y427 | Sugiyama | SHC1 SHC SHCA | RKQMPPPPPCPGRELFDDPsyVNVQNLDKARQAVGGAGPPN |
| P29401 | Y202 | Sugiyama | TKT | LDINRLGQsDPAPLQHQMDIyQKRCEAFGWHAIIVDGHSVE |
| P29401 | Y309 | Sugiyama | TKT | PQEDAPsVDIANIRMPsLPsyKVGDKIATRKAYGQALAKLG |
| P29401 | Y447 | Sugiyama | TKT | SQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAANTKGI |
| P29401 | Y481 | Sugiyama | TKT | AANTKGICFIRTsRPENAIIyNNNEDFQVGQAKVVLKSKDD |
| P29692 | Y26 | Sugiyama | EEF1D EF1D | LAHEKIWFDKFKYDDAERRFyEQMNGPVAGAsRQENGAsVI |
| P30040 | Y115 | Sugiyama | ERP29 C12orf8 ERP28 | DyGDKLNMELSEKYKLDKESyPVFyLFRDGDFENPVPyTGA |
| P30040 | Y119 | Sugiyama | ERP29 C12orf8 ERP28 | KLNMELSEKYKLDKESyPVFyLFRDGDFENPVPyTGAVKVG |
| P30043 | Y205 | Sugiyama | BLVRB FLR SCAN | MLRCLttDEyDGHstyPsHQyQ___________________ |
| P30084 | Y112 | Sugiyama | ECHS1 | KAFAAGADIKEMQNLsFQDCySSKFLKHWDHLTQVKKPVIA |
| P30085 | Y49 | Sugiyama | CMPK1 CMK CMPK UCK UMK UMPK | ytHLSAGELLRDERKNPDsQyGELIEKYIKEGKIVPVEITI |
| P30086 | Y106 | Sugiyama | PEBP1 PBP PEBP | HFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyVWLVyE |
| P30086 | Y120 | Sugiyama | PEBP1 PBP PEBP | GtVLsDyVGsGPPKGtGLHRyVWLVyEQDRPLKCDEPILsN |
| P30086 | Y125 | Sugiyama | PEBP1 PBP PEBP | DyVGsGPPKGtGLHRyVWLVyEQDRPLKCDEPILsNRsGDH |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P30101 | Y100 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAyDGPRt |
| P30101 | Y115 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yGVsGyPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPA |
| P30101 | Y356 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | FVMQEEFsRDGKALERFLQDyFDGNLKRyLKsEPIPESNDG |
| P30101 | Y67 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LMLVEFFAPWCGHCKRLAPEyEAAAtRLKGIVPLAKVDCTA |
| P30101 | Y95 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KGIVPLAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAy |
| P30533 | Y246 | Sugiyama | LRPAP1 A2MRAP | EKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWDLAQS |
| P31327 | Y140 | Sugiyama | CPS1 | YLESNGIKVSGLLVLDYsKDyNHWLATKsLGQWLQEEKVPA |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31946 | Y120 | Sugiyama | YWHAB | LELLDKyLIPNATQPESKVFyLKMKGDYFRyLsEVAsGDNK |
| P31946 | Y151 | Sugiyama | YWHAB | LsEVAsGDNKQTtVsNsQQAyQEAFEIsKKEMQPTHPIRLG |
| P31946 | Y21 | Sugiyama | YWHAB | MTMDKsELVQKAKLAEQAERyDDMAAAMKAVtEQGHELsNE |
| P31946 | Y213 | Sugiyama | YWHAB | LAKTAFDEAIAELDtLNEEsyKDstLIMQLLRDNLtLWtSE |
| P31946 | Y50 | Sugiyama | YWHAB | AVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P31947 | Y120 | Sugiyama | SFN HME1 | LGLLDSHLIKEAGDAESRVFyLKMKGDYYRyLAEVATGDDK |
| P31947 | Y151 | Sugiyama | SFN HME1 | LAEVATGDDKKRIIDSARsAyQEAMDISKKEMPPTNPIRLG |
| P31947 | Y19 | Sugiyama | SFN HME1 | __MERASLIQKAKLAEQAERyEDMAAFMKGAVEKGEELsCE |
| P31947 | Y213 | Sugiyama | SFN HME1 | LAKTtFDEAMADLHtLsEDsyKDstLIMQLLRDNLtLWTAD |
| P31947 | Y48 | Sugiyama | SFN HME1 | GAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsIEQK |
| P31948 | T445 | Sugiyama | STIP1 | PTFIKGYTRKAAALEAMKDytKAMDVYQKALDLDssCKEAA |
| P31948 | Y354 | Sugiyama | STIP1 | DVLKKCQQAEKILKEQERLAyINPDLALEEKNKGNECFQKG |
| P31948 | Y41 | Sugiyama | STIP1 | DDALQCysEAIKLDPHNHVLysNRsAAyAKKGDYQKAyEDG |
| P31948 | Y444 | Sugiyama | STIP1 | EPTFIKGYTRKAAALEAMKDytKAMDVYQKALDLDssCKEA |
| P32119 | Y115 | Sugiyama | PRDX2 NKEFB TDPX1 | GLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFIIDGK |
| P32754 | Y255 | Sugiyama | HPD PPD | SIKMPINEPAPGKKKSQIQEyVDyNGGAGVQHIALKTEDII |
| P32754 | Y258 | Sugiyama | HPD PPD | MPINEPAPGKKKSQIQEyVDyNGGAGVQHIALKTEDIITAI |
| P32929 | S61 | Sugiyama | CTH | ISLSTTFKQGAPGQHsGFEysRsGNPTRNCLEKAVAALDGA |
| P33176 | Y516 | Sugiyama | KIF5B KNS KNS1 | EELAVNyDQKSQEVEDKTKEyELLSDELNQKsATLAsIDAE |
| P33316 | Y167 | Sugiyama | DUT | PPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDVGAG |
| P33316 | Y227 | Sugiyama | DUT | EKFEVKKGDRIAQLICERIFyPEIEEVQALDDtERGsGGFG |
| P33778 | Y41 | Sugiyama | H2BC3 H2BFF HIST1H2BB | KAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P33778 | Y43 | Sugiyama | H2BC3 H2BFF HIST1H2BB | QKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P33993 | Y333 | Sugiyama | MCM7 CDC47 MCM2 | EsGAGELtREELRQIAEEDFyEKLAASIAPEIYGHEDVKKA |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | T39 | Sugiyama | HSPA1L | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P34931 | T40 | Sugiyama | HSPA1L | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P34932 | Y30 | Sugiyama | HSPA4 APG2 HSPH2 | FQSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGA |
| P34932 | Y624 | Sugiyama | HSPA4 APG2 HSPH2 | MIMQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDD |
| P34932 | Y626 | Sugiyama | HSPA4 APG2 HSPH2 | MQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDDRN |
| P35580 | Y13 | Sugiyama | MYH10 | ________MAQRTGLEDPERyLFVDRAVIYNPATQADWTAK |
| P35609 | Y385 | Sugiyama | ACTN2 | GKMVSDIAGAWQRLEQAEKGyEEWLLNEIRRLERLEHLAEK |
| P35637 | Y468 | Sugiyama | FUS TLS | KAPKPDGPGGGPGGsHMGGNyGDDRRGGRGGYDRGGYRGRG |
| P35916 | Y1230 | GPS6|ELM | FLT4 VEGFR3 | AQADAEDsPPSLQRHSLAARyyNWVsFPGCLARGAETRGSS |
| P35916 | Y1231 | GPS6|ELM | FLT4 VEGFR3 | QADAEDsPPSLQRHSLAARyyNWVsFPGCLARGAETRGSSR |
| P35916 | Y1265 | GPS6|ELM | FLT4 VEGFR3 | ETRGSSRMKtFEEFPMTPtTyKGSVDNQTDSGMVLASEEFE |
| P35968 | S1235 | Sugiyama | KDR FLK1 VEGFR2 | DNtAGISQyLQNsKRKSRPVsVKtFEDIPLEEPEVKVIPDD |
| P35968 | S803 | Sugiyama | KDR FLK1 VEGFR2 | VIILRTVKRANGGELKtGyLsIVMDPDELPLDEHCERLPyD |
| P35968 | S982 | Sugiyama | KDR FLK1 VEGFR2 | RLDSITSSQSSASSGFVEEKsLsDVEEEEAPEDLyKDFLTL |
| P35968 | S984 | Sugiyama | KDR FLK1 VEGFR2 | DSITSSQSSASSGFVEEKsLsDVEEEEAPEDLyKDFLTLEH |
| P35968 | T1217 | Sugiyama | KDR FLK1 VEGFR2 | SPVSCMEEEEVCDPKFHyDNtAGISQyLQNsKRKSRPVsVK |
| P35968 | T1238 | Sugiyama | KDR FLK1 VEGFR2 | AGISQyLQNsKRKSRPVsVKtFEDIPLEEPEVKVIPDDNQT |
| P35968 | T799 | Sugiyama | KDR FLK1 VEGFR2 | WLLLVIILRTVKRANGGELKtGyLsIVMDPDELPLDEHCER |
| P35968 | T926 | Sugiyama | KDR FLK1 VEGFR2 | TKPGGPLMVIVEFCKFGNLStYLRSKRNEFVPYKTKGARFR |
| P35968 | Y1054 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | KDR FLK1 VEGFR2 | ILLSEKNVVKICDFGLARDIyKDPDyVRKGDARLPLKWMAP |
| P35968 | Y1059 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | KDR FLK1 VEGFR2 | KNVVKICDFGLARDIyKDPDyVRKGDARLPLKWMAPETIFD |
| P35968 | Y1175 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | KDR FLK1 VEGFR2 | ELVEHLGNLLQANAQQDGKDyIVLPISETLSMEEDSGLSLP |
| P35968 | Y1214 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | KDR FLK1 VEGFR2 | LPTSPVSCMEEEEVCDPKFHyDNtAGISQyLQNsKRKSRPV |
| P35968 | Y1223 | Sugiyama | KDR FLK1 VEGFR2 | EEEEVCDPKFHyDNtAGISQyLQNsKRKSRPVsVKtFEDIP |
| P35968 | Y1305 | GPS6|EPSD | KDR FLK1 VEGFR2 | MVPSKSRESVASEGSNQTSGyQSGyHSDDTDTTVySSEEAE |
| P35968 | Y1309 | GPS6|EPSD | KDR FLK1 VEGFR2 | KSRESVASEGSNQTSGyQSGyHSDDTDTTVySSEEAELLKL |
| P35968 | Y1319 | GPS6|EPSD | KDR FLK1 VEGFR2 | SNQTSGyQSGyHSDDTDTTVySSEEAELLKLIEIGVQTGST |
| P35968 | Y801 | Sugiyama | KDR FLK1 VEGFR2 | LLVIILRTVKRANGGELKtGyLsIVMDPDELPLDEHCERLP |
| P35968 | Y951 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | KDR FLK1 VEGFR2 | KRNEFVPYKTKGARFRQGKDyVGAIPVDLKRRLDSITSSQS |
| P35968 | Y996 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | KDR FLK1 VEGFR2 | GFVEEKsLsDVEEEEAPEDLyKDFLTLEHLICYSFQVAKGM |
| P36578 | S275 | Sugiyama | RPL4 RPL1 | sAFRKLDELyGtWRKAAsLKsNyNLPMHKMINtDLsRILKs |
| P36578 | S63 | Sugiyama | RPL4 RPL1 | NLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGG |
| P36578 | Y277 | Sugiyama | RPL4 RPL1 | FRKLDELyGtWRKAAsLKsNyNLPMHKMINtDLsRILKsPE |
| P36578 | Y52 | Sugiyama | RPL4 RPL1 | IRPDIVNFVHTNLRKNNRQPyAVsELAGHQtsAEsWGtGRA |
| P36871 | Y476 | Sugiyama | PGM1 | GKQFSANDKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTD |
| P37108 | Y83 | Sugiyama | SRP14 | GKKKISTVVSSKEVNKFQMAysNLLRANMDGLKKRDKKNKT |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P38646 | Y196 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | EtAENyLGHtAKNAVItVPAyFNDsQRQAtKDAGQIsGLNV |
| P38919 | Y54 | Sugiyama | EIF4A3 DDX48 KIAA0111 | VDVTPTFDTMGLREDLLRGIyAyGFEKPsAIQQRAIKQIIK |
| P38919 | Y56 | Sugiyama | EIF4A3 DDX48 KIAA0111 | VTPTFDTMGLREDLLRGIyAyGFEKPsAIQQRAIKQIIKGR |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P40227 | Y109 | Sugiyama | CCT6A CCT6 CCTZ | GDGTTsNVLIIGELLKQADLyISEGLHPRIITEGFEAAKEK |
| P40261 | Y11 | Sugiyama | NNMT | __________MESGFTSKDTyLSHFNPRDYLEKYYKFGSRH |
| P40429 | Y149 | Sugiyama | RPL13A | LKPTRKFAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYR |
| P40926 | Y80 | Sugiyama | MDH2 | HtPGVAADLsHIEtKAAVKGyLGPEQLPDCLKGCDVVVIPA |
| P41091 | Y102 | Sugiyama | EIF2S3 EIF2G | GYANAKIYKLDDPSCPRPECyRSCGsstPDEFPtDIPGtKG |
| P41227 | Y145 | Sugiyama | NAA10 ARD1 ARD1A TE2 | TLNFQISEVEPKyyADGEDAyAMKRDLtQMADELRRHLELK |
| P41567 | Y30 | Sugiyama | EIF1 SUI1 | FDPFADAsKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| P42025 | Y33 | Sugiyama | ACTR1B CTRN2 | VIDNGSGVIKAGFAGDQIPKyCFPNyVGRPKHMRVMAGALE |
| P42025 | Y38 | Sugiyama | ACTR1B CTRN2 | SGVIKAGFAGDQIPKyCFPNyVGRPKHMRVMAGALEGDLFI |
| P42224 | Y170 | Sugiyama | STAT1 | KDKVMCIEHEIKsLEDLQDEyDFKCKTLQNREHETNGVAKS |
| P42765 | Y198 | Sugiyama | ACAA2 | ECDKyALQSQQRWKAANDAGyFNDEMAPIEVKTKKGKQTMQ |
| P42766 | Y114 | Sugiyama | RPL35 | RLNKHEENLKTKKQQRKERLyPLRKYAVKA___________ |
| P43243 | Y202 | Sugiyama | MATR3 KIAA0723 | RHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyDRMDyEDD |
| P46776 | S106 | Sugiyama | RPL27A | tRVNAAKNKtGAAPIIDVVRsGyyKVLGKGKLPKQPVIVKA |
| P46776 | Y108 | Sugiyama | RPL27A | VNAAKNKtGAAPIIDVVRsGyyKVLGKGKLPKQPVIVKAKF |
| P46776 | Y109 | Sugiyama | RPL27A | NAAKNKtGAAPIIDVVRsGyyKVLGKGKLPKQPVIVKAKFF |
| P46776 | Y48 | Sugiyama | RPL27A | HPGGRGNAGGLHHHRINFDKyHPGyFGKVGMKHYHLKRNQs |
| P46776 | Y52 | Sugiyama | RPL27A | RGNAGGLHHHRINFDKyHPGyFGKVGMKHYHLKRNQsFCPt |
| P46777 | Y207 | Sugiyama | RPL5 MSTP030 | sKEFNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyI |
| P46777 | Y210 | Sugiyama | RPL5 MSTP030 | FNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyIKNs |
| P46777 | Y219 | Sugiyama | RPL5 MSTP030 | IMGQNVADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEM |
| P46777 | Y226 | Sugiyama | RPL5 MSTP030 | DyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAA |
| P46777 | Y240 | Sugiyama | RPL5 MSTP030 | KKQFsQyIKNsVtPDMMEEMyKKAHAAIRENPVyEKKPKKE |
| P46777 | Y253 | Sugiyama | RPL5 MSTP030 | PDMMEEMyKKAHAAIRENPVyEKKPKKEVKKKRWNRPKMsL |
| P46778 | Y156 | Sugiyama | RPL21 | REAHFVRTNGKEPELLEPIPyEFMA________________ |
| P46778 | Y30 | Sugiyama | RPL21 | GTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQK |
| P46937 | Y407 | Sugiyama | YAP1 YAP65 | NsGtyHsRDEstDsGLsMssysVPRtPDDFLNsVDEMDTGD |
| P46940 | Y654 | Sugiyama | IQGAP1 KIAA0051 | VESGDVGKtLsALRsPDVGLyGVIPECGEtyHsDLAEAKKK |
| P46940 | Y664 | Sugiyama | IQGAP1 KIAA0051 | sALRsPDVGLyGVIPECGEtyHsDLAEAKKKKLAVGDNNSK |
| P46976 | Y332 | Sugiyama | GYG1 GYG | AQPFVSSEERKERWEQGQADyMGADSFDNIKRKLDTYLQ__ |
| P47224 | Y114 | Sugiyama | RABIF MSS4 RASGRF3 | CADCEIGPIGWHCLDDKNSFyVALERVSHE___________ |
| P47813 | Y35 | Sugiyama | EIF1AX EIF1A EIF4C | GKNENESEKRELVFKEDGQEyAQVIKMLGNGRLEAMCFDGV |
| P47914 | Y98 | Sugiyama | RPL29 | PKEVKPKIPKGVSRKLDRLAyIAHPKLGKRARARIAKGLRL |
| P48643 | Y274 | Sugiyama | CCT5 CCTE KIAA0098 | PFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQQIKE |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P49207 | Y32 | Sugiyama | RPL34 | sYNtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGR |
| P49207 | Y34 | Sugiyama | RPL34 | NtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGRLR |
| P49327 | Y2462 | Sugiyama | FASN FAS | NVMLLRAKtGGAyGEDLGADyNLsQVCDGKVsVHVIEGDHR |
| P49327 | Y289 | Sugiyama | FASN FAS | QEQLIRSLyQsAGVAPEsFEyIEAHGtGTKVGDPQELNGIt |
| P49588 | Y192 | Sugiyama | AARS1 AARS | KDNFWEMGDtGPCGPCsEIHyDRIGGRDAAHLVNQDDPNVL |
| P50502 | Y185 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | NAAIRDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEAAHDL |
| P50914 | Y14 | Sugiyama | RPL14 | _______MVFRRFVEVGRVAyVsFGPHAGKLVAIVDVIDQN |
| P50990 | Y30 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | GFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTTRTAYGPN |
| P50991 | Y269 | Sugiyama | CCT4 CCTD SRB | IQFCLSAPKTDMDNQIVVSDyAQMDRVLREERAYILNLVKQ |
| P50995 | Y493 | Sugiyama | ANXA11 ANX11 | YKRMYGKsLyHDISGDtsGDyRKILLKICGGND________ |
| P51116 | Y614 | Sugiyama | FXR2 FMR1L2 | RGNRtDGsIsGDRQPVtVADyIsRAEsQsRQRPPLERTKPs |
| P51858 | S69 | Sugiyama | HDGF HMG1L2 | FFGTHETAFLGPKDLFPyEEsKEKFGKPNKRKGFsEGLWEI |
| P51858 | Y66 | Sugiyama | HDGF HMG1L2 | QVFFFGTHETAFLGPKDLFPyEEsKEKFGKPNKRKGFsEGL |
| P52565 | T160 | Sugiyama | ARHGDIA GDIA1 | DKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYsIKSR |
| P52565 | Y156 | Sugiyama | ARHGDIA GDIA1 | GVKIDKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYs |
| P52597 | Y82 | Sugiyama | HNRNPF HNRPF | GsEDDVKMALKKDRESMGHRyIEVFKSHRTEMDWVLKHsGP |
| P52888 | Y576 | Sugiyama | THOP1 | VLAKVDQALHTQTDADPAEEyARLCQEILGVPATPGTNMPA |
| P52948 | T743 | Sugiyama | NUP98 ADAR2 | ENNsYHMHPAGIILtKVGyytIPsMDDLAKITNEKGECIVS |
| P52948 | Y208 | Sugiyama | NUP98 ADAR2 | CITAMKEYESKSLEELRLEDyQANRKGPQNQVGAGTTTGLF |
| P52948 | Y627 | Sugiyama | NUP98 ADAR2 | NsNLFsPVNRDsENLAsPsEyPENGERFsFLSKPVDENHQQ |
| P52948 | Y741 | Sugiyama | NUP98 ADAR2 | EIENNsYHMHPAGIILtKVGyytIPsMDDLAKITNEKGECI |
| P52948 | Y742 | Sugiyama | NUP98 ADAR2 | IENNsYHMHPAGIILtKVGyytIPsMDDLAKITNEKGECIV |
| P52948 | Y848 | Sugiyama | NUP98 ADAR2 | PTDKTSRCLIKsPDRLADINyEGRLEAVSRKQGAQFKEyRP |
| P53634 | Y438 | Sugiyama | CTSC CPPI | SGMDYWIVKNsWGtGWGENGyFRIRRGtDECAIEsIAVAAt |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P54105 | Y214 | Sugiyama | CLNS1A CLCI ICLN | QsVssQYNMAGVRtEDsIRDyEDGMEVDttPtVAGQFEDAD |
| P54577 | Y388 | Sugiyama | YARS1 YARS | LDIRVGKIITVEKHPDADsLyVEKIDVGEAEPRTVVSGLVQ |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | T38 | Sugiyama | HSPA2 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P54652 | T39 | Sugiyama | HSPA2 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55060 | S366 | Sugiyama | CSE1L CAS XPO2 | KVIVPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAA |
| P55060 | Y369 | Sugiyama | CSE1L CAS XPO2 | VPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAACDL |
| P55081 | Y276 | Sugiyama | MFAP1 | KRsLAALDALNtDDENDEEEyEAWKVRELKRIKRDREDREA |
| P55209 | Y66 | Sugiyama | NAP1L1 NRP | PQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQV |
| P55209 | Y96 | Sugiyama | NAP1L1 NRP | RRVNALKNLQVKCAQIEAKFyEEVHDLERKyAVLyQPLFDK |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P57053 | Y41 | Sugiyama | H2BC12L H2BFS H2BS1 | KAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P57053 | Y43 | Sugiyama | H2BC12L H2BFS H2BS1 | QKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P58876 | Y41 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P58876 | Y43 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P60174 | Y209 | Sugiyama | TPI1 TPI | LRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDG |
| P60660 | S30 | Sugiyama | MYL6 | AEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVLK |
| P60660 | Y29 | Sugiyama | MYL6 | TAEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVL |
| P60660 | Y86 | Sugiyama | MYL6 | DFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMG |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | S365 | Sugiyama | ACTB | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | Y198 | Sugiyama | ACTB | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y362 | Sugiyama | ACTB | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P60842 | Y48 | Sugiyama | EIF4A1 DDX2A EIF4A | NEIVDSFDDMNLSESLLRGIyAyGFEKPsAIQQRAILPCIK |
| P60842 | Y50 | Sugiyama | EIF4A1 DDX2A EIF4A | IVDSFDDMNLSESLLRGIyAyGFEKPsAIQQRAILPCIKGy |
| P60842 | Y70 | Sugiyama | EIF4A1 DDX2A EIF4A | yGFEKPsAIQQRAILPCIKGyDVIAQAQsGtGKTATFAISI |
| P60900 | Y159 | Sugiyama | PSMA6 PROS27 | ILIGIDEEQGPQVYKCDPAGyyCGFKATAAGVKQtEstsFL |
| P60900 | Y160 | Sugiyama | PSMA6 PROS27 | LIGIDEEQGPQVYKCDPAGyyCGFKATAAGVKQtEstsFLE |
| P61024 | Y19 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | __MSHKQIyysDKyDDEEFEyRHVMLPKDIAKLVPKTHLMs |
| P61024 | Y7 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | ______________MSHKQIyysDKyDDEEFEyRHVMLPKD |
| P61158 | Y231 | Sugiyama | ACTR3 ARP3 | REVGIPPEQSLETAKAVKERysyVCPDLVKEFNKYDTDGSK |
| P61158 | Y233 | Sugiyama | ACTR3 ARP3 | VGIPPEQSLETAKAVKERysyVCPDLVKEFNKYDTDGSKWI |
| P61163 | Y33 | Sugiyama | ACTR1A CTRN1 | VIDNGSGVIKAGFAGDQIPKyCFPNyVGRPKHVRVMAGALE |
| P61163 | Y38 | Sugiyama | ACTR1A CTRN1 | SGVIKAGFAGDQIPKyCFPNyVGRPKHVRVMAGALEGDIFI |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P61247 | Y256 | Sugiyama | RPS3A FTE1 MFTL | sssGKAtGDEtGAKVERADGyEPPVQEsV____________ |
| P61247 | Y31 | Sugiyama | RPS3A FTE1 MFTL | KGGKKGAKKKVVDPFSKKDWyDVKAPAMFNIRNIGKTLVTR |
| P61313 | T80 | Sugiyama | RPL15 EC45 TCBAP0781 | VIyRIRVRRGGRKRPVPKGAtyGKPVHHGVNQLKFARsLQs |
| P61313 | Y59 | Sugiyama | RPL15 EC45 TCBAP0781 | APRPTRPDKARRLGYKAKQGyVIyRIRVRRGGRKRPVPKGA |
| P61313 | Y81 | Sugiyama | RPL15 EC45 TCBAP0781 | IyRIRVRRGGRKRPVPKGAtyGKPVHHGVNQLKFARsLQsV |
| P61353 | S39 | Sugiyama | RPL27 | SGRKAVIVKNIDDGtsDRPysHALVAGIDRyPRKVTAAMGK |
| P61353 | T94 | Sugiyama | RPL27 | VyNyNHLMPtRysVDIPLDKtVVNKDVFRDPALKRKARREA |
| P61353 | Y75 | Sugiyama | RPL27 | AAMGKKKIAKRSKIKSFVKVyNyNHLMPtRysVDIPLDKtV |
| P61353 | Y77 | Sugiyama | RPL27 | MGKKKIAKRSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVN |
| P61353 | Y85 | Sugiyama | RPL27 | RSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPA |
| P61586 | Y156 | Sugiyama | RHOA ARH12 ARHA RHO12 | QEPVKPEEGRDMANRIGAFGyMECsAKTKDGVREVFEMAtR |
| P61604 | Y100 | Sugiyama | HSPE1 | KVVLDDKDyFLFRDGDILGKyVD__________________ |
| P61604 | Y88 | Sugiyama | HSPE1 | GDKVLLPEyGGtKVVLDDKDyFLFRDGDILGKyVD______ |
| P61978 | Y323 | Sugiyama | HNRNPK HNRPK | RARNLPLPPPPPPRGGDLMAyDRRGRPGDRYDGMVGFSADE |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P61981 | Y123 | Sugiyama | YWHAG | LLDNYLIKNCsETQyEsKVFyLKMKGDYYRYLAEVATGEKR |
| P61981 | Y20 | Sugiyama | YWHAG | _MVDREQLVQKARLAEQAERyDDMAAAMKNVtELNEPLsNE |
| P61981 | Y216 | Sugiyama | YWHAG | LAKtAFDDAIAELDtLNEDsyKDstLIMQLLRDNLtLWtsD |
| P61981 | Y49 | Sugiyama | YWHAG | NVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P62081 | Y177 | Sugiyama | RPS7 | HLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEFQL___ |
| P62191 | Y184 | Sugiyama | PSMC1 | MDDTDPLVTVMKVEKAPQETyADIGGLDNQIQEIKESVELP |
| P62241 | Y198 | Sugiyama | RPS8 OK/SW-cl.83 | RPGQCGRADGyVLEGKELEFyLRKIKARKGK__________ |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62258 | T137 | Sugiyama | YWHAE | sKVFyyKMKGDYHRyLAEFAtGNDRKEAAENsLVAyKAAsD |
| P62258 | Y131 | Sugiyama | YWHAE | AANtGEsKVFyyKMKGDYHRyLAEFAtGNDRKEAAENsLVA |
| P62258 | Y152 | Sugiyama | YWHAE | LAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLG |
| P62258 | Y20 | Sugiyama | YWHAE | _MDDREDLVyQAKLAEQAERyDEMVESMKKVAGMDVELTVE |
| P62258 | Y214 | Sugiyama | YWHAE | LAKAAFDDAIAELDtLsEEsyKDstLIMQLLRDNLtLWtsD |
| P62258 | Y49 | Sugiyama | YWHAE | KVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssIEQK |
| P62263 | S70 | Sugiyama | RPS14 PRO2640 | KETICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELGI |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62277 | Y18 | Sugiyama | RPS13 | ___MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVKEQIy |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62280 | Y55 | Sugiyama | RPS11 | RYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILsG |
| P62633 | Y120 | Sugiyama | CNBP RNF163 ZNF9 | NCGKPGHLARDCDHADEQKCysCGEFGHIQKDCTKVKCYRC |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62750 | Y74 | Sugiyama | RPL23A | LRRQPKYPRKSAPRRNKLDHyAIIKFPLTTEsAMKKIEDNN |
| P62753 | Y156 | Sugiyama | RPS6 OK/SW-cl.2 | KRASRIRKLFNLsKEDDVRQyVVRKPLNKEGKKPRTKAPKI |
| P62807 | Y41 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P62807 | Y43 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | QKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P62826 | Y146 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IKDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLAR |
| P62826 | Y147 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLARK |
| P62829 | Y38 | Sugiyama | RPL23 | LGLPVGAVINCADNTGAKNLyIIsVKGIKGRLNRLPAAGVG |
| P62847 | Y76 | Sugiyama | RPS24 | FVFGFRTHFGGGKttGFGMIyDsLDyAKKNEPKHRLARHGL |
| P62847 | Y81 | Sugiyama | RPS24 | RTHFGGGKttGFGMIyDsLDyAKKNEPKHRLARHGLYEKKK |
| P62899 | T104 | Sugiyama | RPL31 | IRVRLSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDE |
| P62899 | T107 | Sugiyama | RPL31 | RLSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN__ |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62899 | Y103 | Sugiyama | RPL31 | RIRVRLSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVD |
| P62899 | Y108 | Sugiyama | RPL31 | LSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN___ |
| P62899 | Y25 | Sugiyama | RPL31 | KKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRA |
| P62906 | Y11 | Sugiyama | RPL10A NEDD6 | __________MSSKVsRDtLyEAVREVLHGNQRKRRKFLET |
| P62910 | Y95 | Sugiyama | RPL32 PP9932 | RKFLVHNVKELEVLLMCNKsyCAEIAHNVSsKNRKAIVERA |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62937 | Y79 | Sugiyama | PPIA CYPA | GFMCQGGDFtRHNGTGGKsIyGEKFEDENFILKHtGPGILs |
| P62942 | T28 | Sugiyama | FKBP1A FKBP1 FKBP12 | IsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPFK |
| P62942 | Y27 | Sugiyama | FKBP1A FKBP1 FKBP12 | tIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPF |
| P62979 | Y148 | Sugiyama | RPS27A UBA80 UBCEP1 | AGVFMAsHFDRHyCGKCCLtyCFNKPEDK____________ |
| P63010 | Y524 | Sugiyama | AP2B1 ADTB2 CLAPB1 | QQVLSLATQDSDNPDLRDRGyIyWRLLsTDPVTAKEVVLSE |
| P63010 | Y526 | Sugiyama | AP2B1 ADTB2 CLAPB1 | VLSLATQDSDNPDLRDRGyIyWRLLsTDPVTAKEVVLSEKP |
| P63104 | S156 | Sugiyama | YWHAZ | DDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLGLALNFSV |
| P63104 | S210 | Sugiyama | YWHAZ | SLAKtAFDEAIAELDtLsEEsyKDstLIMQLLRDNLtLWts |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63104 | Y118 | Sugiyama | YWHAZ | LsLLEKFLIPNAsQAEsKVFyLKMKGDYYRyLAEVAAGDDK |
| P63104 | Y149 | Sugiyama | YWHAZ | LAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLG |
| P63104 | Y211 | Sugiyama | YWHAZ | LAKtAFDEAIAELDtLsEEsyKDstLIMQLLRDNLtLWtsD |
| P63104 | Y48 | Sugiyama | YWHAZ | sVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssIEQK |
| P63173 | Y41 | Sugiyama | RPL38 | KSVKIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLP |
| P63173 | Y43 | Sugiyama | RPL38 | VKIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLPPG |
| P63220 | T52 | Sugiyama | RPS21 | IQMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRL |
| P63220 | Y53 | Sugiyama | RPS21 | QMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRLA |
| P63261 | S365 | Sugiyama | ACTG1 ACTG | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | Y198 | Sugiyama | ACTG1 ACTG | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y362 | Sugiyama | ACTG1 ACTG | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | T126 | Sugiyama | YBX1 NSEP1 YB1 | GEtVEFDVVEGEKGAEAANVtGPGGVPVQGsKYAADRNHYR |
| P67809 | Y196 | Sugiyama | YBX1 NSEP1 YB1 | sAPEGQAQQRRPyRRRRFPPyyMRRPYGRRPQysNPPVQGE |
| P67809 | Y197 | Sugiyama | YBX1 NSEP1 YB1 | APEGQAQQRRPyRRRRFPPyyMRRPYGRRPQysNPPVQGEV |
| P67809 | Y72 | Sugiyama | YBX1 NSEP1 YB1 | KKVIATKVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68104 | Y29 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P68363 | T94 | Sugiyama | TUBA1B | VIDEVRtGtyRQLFHPEQLItGKEDAANNyARGHYTIGKEI |
| P68363 | Y103 | Sugiyama | TUBA1B | yRQLFHPEQLItGKEDAANNyARGHYTIGKEIIDLVLDRIR |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P68366 | T94 | Sugiyama | TUBA4A TUBA1 | VIDEIRNGPYRQLFHPEQLItGKEDAANNyARGHYTIGKEI |
| P68366 | Y103 | Sugiyama | TUBA4A TUBA1 | YRQLFHPEQLItGKEDAANNyARGHYTIGKEIIDPVLDRIR |
| P68400 | Y12 | Sugiyama | CSNK2A1 CK2A1 | _________MSGPVPSRARVytDVNTHRPREYWDYESHVVE |
| P78371 | T474 | Sugiyama | CCT2 99D8.1 CCTB | AGYDSADLVAQLRAAHsEGNttAGLDMREGTIGDMAILGIT |
| P80303 | Y350 | Sugiyama | NUCB2 NEFA | PDsWEtLDQQQFFtEEELKEyENIIALQENELKKKADELQK |
| P83731 | Y11 | Sugiyama | RPL24 | __________MKVELCsFsGyKIYPGHGRRYARTDGKVFQF |
| P84103 | Y32 | Sugiyama | SRSF3 SFRS3 SRP20 | VyVGNLGNNGNKtELERAFGyyGPLRSVWVARNPPGFAFVE |
| P84103 | Y33 | Sugiyama | SRSF3 SFRS3 SRP20 | yVGNLGNNGNKtELERAFGyyGPLRSVWVARNPPGFAFVEF |
| P98082 | Y38 | Sugiyama | DAB2 DOC2 | AAPKAPsKKEKKKGPEKTDEyLLARFKGDGVKYKAKLIGID |
| Q00341 | Y40 | Sugiyama | HDLBP HBP VGL | VPQQIKVAtLNsEEEsDPPtyKDAFPPLPEKAACLESAQEP |
| Q00526 | Y15 | Sugiyama | CDK3 CDKN3 | ______MDMFQKVEKIGEGtyGVVyKAKNRETGQLVALKKI |
| Q00610 | Y1487 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | LNNLFITEEDyQALRTsIDAyDNFDNIsLAQRLEKHELIEF |
| Q00610 | Y883 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | EARIHEGCEEPAtHNALAKIyIDsNNNPERFLRENPyyDsR |
| Q00839 | Y257 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QKGGDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVE |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | Y135 | Sugiyama | SET | EALHYLTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLSKE |
| Q01105 | Y140 | Sugiyama | SET | LTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNE |
| Q01105 | Y146 | Sugiyama | SET | tEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNEsGDPss |
| Q01130 | Y44 | Sugiyama | SRSF2 SFRS2 | RtsPDtLRRVFEKYGRVGDVyIPRDRYTKESRGFAFVRFHD |
| Q01469 | Y22 | Sugiyama | FABP5 | ATVQQLEGRWRLVDSKGFDEyMKELGVGIALRKMGAMAKPD |
| Q02878 | Y115 | Sugiyama | RPL6 TXREB1 | PVGGDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQ |
| Q02878 | Y116 | Sugiyama | RPL6 TXREB1 | VGGDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQH |
| Q02878 | Y216 | Sugiyama | RPL6 TXREB1 | AtsTKIDISNVKIPKHLtDAyFKKKKLRKPRHQEGEIFDtE |
| Q04446 | Y657 | Sugiyama | GBE1 | RVGTALPGKFKIVLDSDAAEyGGHQRLDHSTDFFSEAFEHN |
| Q04637 | Y596 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | SKEDKIHNAENIQPGEQKyEyKsDQWKPLNLEEKKRYDREF |
| Q04695 | Y398 | Sugiyama | KRT17 | EQEIATyRRLLEGEDAHLTQyKKEPVTTRQVRtIVEEVQDG |
| Q04760 | Y49 | Sugiyama | GLO1 | DFLLQQtMLRVKDPKKSLDFyTRVLGMtLIQKCDFPIMKFS |
| Q04837 | Y73 | Sugiyama | SSBP1 SSBP | PVTIFSLATNEMWRsGDsEVyQLGDVsQKTTWHRISVFRPG |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q04917 | Y123 | Sugiyama | YWHAH YWHA1 | LLDKFLIKNCNDFQYESKVFyLKMKGDYYRYLAEVASGEKK |
| Q04917 | Y154 | Sugiyama | YWHAH YWHA1 | LAEVASGEKKNsVVEAsEAAyKEAFEISKEQMQPTHPIRLG |
| Q04917 | Y20 | Sugiyama | YWHAH YWHA1 | _MGDREQLLQRARLAEQAERyDDMAsAMKAVtELNEPLsNE |
| Q04917 | Y49 | Sugiyama | YWHAH YWHA1 | AVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSIEQK |
| Q05639 | Y29 | Sugiyama | EEF1A2 EEF1AL STN | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q07021 | Y188 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | FVVEVIKNDDGKKALVLDCHyPEDEVGQEDEAEsDIFsIRE |
| Q07666 | Y145 | Sugiyama | KHDRBS1 SAM68 | LtAEIEKIQKGDSKKDDEENyLDLFsHKNMKLKERVLIPVK |
| Q07955 | Y189 | Sugiyama | SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3 | TYAVRKLDNTKFRsHEGEtAyIRVKVDGPRsPsyGRsRsRs |
| Q07955 | Y37 | Sugiyama | SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3 | RIyVGNLPPDIRtKDIEDVFyKYGAIRDIDLKNRRGGPPFA |
| Q08211 | Y132 | Sugiyama | DHX9 DDX9 LKP NDH2 | PLPPHLALKAENNsEVGAsGyGVPGPTWDRGANLKDYYSRK |
| Q08211 | Y616 | Sugiyama | DHX9 DDX9 LKP NDH2 | KDDDGGEDDDANCNLICGDEyGPETRLsMsQLNEKETPFEL |
| Q08J23 | Y51 | Sugiyama | NSUN2 SAKI TRM4 | EAGWEGGyPEIVKENKLFEHyyQELKIVPEGEWGQFMDALR |
| Q08J23 | Y52 | Sugiyama | NSUN2 SAKI TRM4 | AGWEGGyPEIVKENKLFEHyyQELKIVPEGEWGQFMDALRE |
| Q08J23 | Y537 | Sugiyama | NSUN2 SAKI TRM4 | EDPFVFIPEDDPLFPPIEKFyALDPSFPRMNLLTRTTEGKK |
| Q09028 | Y154 | Sugiyama | RBBP4 RBAP48 | PQNPCIIATKtPssDVLVFDyTKHPsKPDPsGECNPDLRLR |
| Q10567 | Y524 | Sugiyama | AP1B1 ADTB1 BAM22 CLAPB2 | QQVLSLATQDSDNPDLRDRGyIyWRLLsTDPVAAKEVVLAE |
| Q10567 | Y526 | Sugiyama | AP1B1 ADTB1 BAM22 CLAPB2 | VLSLATQDSDNPDLRDRGyIyWRLLsTDPVAAKEVVLAEKP |
| Q12792 | Y53 | Sugiyama | TWF1 PTK9 | ENEQLVIGSYSQPSDSWDKDyDsFVLPLLEDKQPCYILFRL |
| Q12904 | Y288 | Sugiyama | AIMP1 EMAP2 SCYE1 | KKIWEQIQPDLHtNDECVAtyKGVPFEVKGKGVCRAQTMSN |
| Q12931 | Y513 | Sugiyama | TRAP1 HSP75 HSPC5 | GtRNIyyLCAPNRHLAEHsPyyEAMKKKDTEVLFCFEQFDE |
| Q12931 | Y514 | Sugiyama | TRAP1 HSP75 HSPC5 | tRNIyyLCAPNRHLAEHsPyyEAMKKKDTEVLFCFEQFDEL |
| Q13098 | Y172 | Sugiyama | GPS1 COPS1 CSN1 | YKGNSIKESIRRGHDDLGDHyLDCGDLSNALKCYSRARDYC |
| Q13242 | Y17 | Sugiyama | SRSF9 SFRS9 SRP30C | ____MsGWADERGGEGDGRIyVGNLPTDVREKDLEDLFyKY |
| Q13263 | T514 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | DLDLtADsQPPVFKVFPGsttEDyNLIVIERGAAAAATGQP |
| Q13263 | Y133 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | TVVDCPVCKQQCFSKDIVENyFMRDsGsKAATDAQDANQCC |
| Q13263 | Y517 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | LtADsQPPVFKVFPGsttEDyNLIVIERGAAAAATGQPGtA |
| Q13303 | Y270 | Sugiyama | KCNAB2 KCNA2B KCNK2 | IVSGKYDSGIPPYSRAsLKGyQWLKDKILSEEGRRQQAKLK |
| Q13310 | Y194 | Sugiyama | PABPC4 APP1 PABP4 | KSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELFsQF |
| Q13405 | Y45 | Sugiyama | MRPL49 C11orf4 NOF1 OK/SW-cl.67 | LLSQTQGPPDYPRFVEsVDEyQFVERLLPATRIPDPPKHEH |
| Q13435 | Y591 | Sugiyama | SF3B2 SAP145 | LHDAFFKWQTKPKLTIHGDLyyEGKEFETRLKEKKPGDLSD |
| Q13435 | Y592 | Sugiyama | SF3B2 SAP145 | HDAFFKWQTKPKLTIHGDLyyEGKEFETRLKEKKPGDLSDE |
| Q13442 | Y17 | Sugiyama | PDAP1 HASPP28 | ____MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREE |
| Q13442 | Y70 | Sugiyama | PDAP1 HASPP28 | DPKKEKKsLDsDEsEDEEDDyQQKRKGVEGLIDIENPNRVA |
| Q13509 | T107 | Sugiyama | TUBB3 TUBB4 | PDNFIFGQSGAGNNWAKGHytEGAELVDsVLDVVRKECENC |
| Q13509 | Y106 | Sugiyama | TUBB3 TUBB4 | RPDNFIFGQSGAGNNWAKGHytEGAELVDsVLDVVRKECEN |
| Q13642 | Y9 | Sugiyama | FHL1 SLIM1 | ____________MAEKFDCHyCRDPLQGKKYVQKDGHHCCL |
| Q13765 | Y120 | Sugiyama | NACA HSD48 | KNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAAA |
| Q13885 | T107 | Sugiyama | TUBB2A TUBB2 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q13885 | Y106 | Sugiyama | TUBB2A TUBB2 | RPDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESES |
| Q14152 | S1256 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EDRFRRPRDEGGWRRGPAEEsssWRDssRRDDRDRDDRRRE |
| Q14157 | Y858 | Sugiyama | UBAP2L KIAA0144 NICE4 | PFPtPttPLtGRDGsLAsNPysGDLtKFGRGDASSPAPATT |
| Q14192 | Y97 | Sugiyama | FHL2 DRAL SLIM3 | DKPFAAKEDQLLCTDCySNEySSKCQECKKTIMPGTRKMEY |
| Q14240 | Y49 | Sugiyama | EIF4A2 DDX2B EIF4F | NEIVDNFDDMNLKESLLRGIyAyGFEKPsAIQQRAIIPCIK |
| Q14240 | Y51 | Sugiyama | EIF4A2 DDX2B EIF4F | IVDNFDDMNLKESLLRGIyAyGFEKPsAIQQRAIIPCIKGy |
| Q14240 | Y71 | Sugiyama | EIF4A2 DDX2B EIF4F | yGFEKPsAIQQRAIIPCIKGyDVIAQAQsGtGKTATFAISI |
| Q14247 | Y289 | Sugiyama | CTTN EMS1 | FGGKFGVQsERQDsAAVGFDyKEKLAKHEsQQDySKGFGGK |
| Q14247 | Y334 | Sugiyama | CTTN EMS1 | KDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKtsNIRANF |
| Q14247 | Y538 | Sugiyama | CTTN EMS1 | IITNIEMIDDGWWRGVCKGRyGLFPANyVELRQ________ |
| Q14247 | Y545 | Sugiyama | CTTN EMS1 | IDDGWWRGVCKGRyGLFPANyVELRQ_______________ |
| Q14257 | Y215 | Sugiyama | RCN2 ERC55 | LEEHDKNGDGFVsLEEFLGDyRWDPTANEDPEWILVEKDRF |
| Q14257 | Y303 | Sugiyama | RCN2 ERC55 | LsEEEILENPDLFLtsEAtDyGRQLHDDyFyHDEL______ |
| Q14257 | Y311 | Sugiyama | RCN2 ERC55 | NPDLFLtsEAtDyGRQLHDDyFyHDEL______________ |
| Q14257 | Y313 | Sugiyama | RCN2 ERC55 | DLFLtsEAtDyGRQLHDDyFyHDEL________________ |
| Q14257 | Y39 | Sugiyama | RCN2 ERC55 | AAGAGKAEELHyPLGERRsDyDREALLGVQEDVDEyVKLGH |
| Q14257 | Y54 | Sugiyama | RCN2 ERC55 | ERRsDyDREALLGVQEDVDEyVKLGHEEQQKRLQAIIKKID |
| Q14258 | Y245 | Sugiyama | TRIM25 EFP RNF147 ZNF147 | NRQQDVRMTANRKVEQLQQEytEMKALLDASETTSTRKIKE |
| Q14444 | Y99 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | QERMNKGERLNQDQLDAVsKyQEVtNNLEFAKELQRsFMAL |
| Q14566 | Y276 | Sugiyama | MCM6 | KLSTPGARAEtNsRVsGVDGyEtEGIRGLRALGVRDLSYRL |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14671 | Y83 | Sugiyama | PUM1 KIAA0099 PUMH1 | SPVPGSIGVAGRsQDDAMVDyFFQRQHGEQLGGGGsGGGGy |
| Q14677 | Y114 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | SERVVTSAREHIyDLRSLENyHFVDEHGKDQGINIRQKVKE |
| Q14683 | Y516 | Sugiyama | SMC1A DXS423E KIAA0178 SB1.8 SMC1 SMC1L1 | RQQRKAEIMESIKRLYPGsVyGRLIDLCQPTQKKYQIAVTK |
| Q14696 | Y58 | Sugiyama | MESD KIAA0081 MESDC2 MESDM UNQ1911/PRO4369 | PGTPDESTPPPRKKKKDIRDyNDADMARLLEQWEKDDDIEE |
| Q14697 | Y489 | Sugiyama | GANAB G2AN KIAA0088 | PHIKVDSGyRVHEELRNLGLyVKtRDGSDyEGWCWPGSAGY |
| Q15056 | Y101 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | FKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRKQ |
| Q15056 | Y86 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | sIRsVRLVRDKDTDKFKGFCyVEFDEVDsLKEALtyDGALL |
| Q15181 | Y169 | Sugiyama | PPA1 IOPPP PP | EGETDWKVIAINVDDPDAANyNDINDVKRLKPGYLEATVDW |
| Q15185 | S113 | Sugiyama | PTGES3 P23 TEBP | RAKLNWLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGD |
| Q15293 | S80 | Sugiyama | RCN1 RCN | HEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGDGFVt |
| Q15293 | T144 | Sugiyama | RCN1 RCN | WKDYDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtF |
| Q15293 | Y115 | Sugiyama | RCN1 RCN | GDGFVttEELKtWIKRVQKRyIFDNVAKVWKDYDRDKDDKI |
| Q15293 | Y140 | Sugiyama | RCN1 RCN | VAKVWKDYDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssD |
| Q15293 | Y145 | Sugiyama | RCN1 RCN | KDYDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtFK |
| Q15293 | Y147 | Sugiyama | RCN1 RCN | YDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtFKKM |
| Q15293 | Y148 | Sugiyama | RCN1 RCN | DRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtFKKML |
| Q15293 | Y228 | Sugiyama | RCN1 RCN | VLEtLEDIDKNGDGFVDQDEyIADMFSHEENGPEPDWVLSE |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15369 | Y18 | Sugiyama | ELOC TCEB1 | ___MDGEEKtyGGCEGPDAMyVKLISSDGHEFIVKREHALt |
| Q15427 | Y16 | Sugiyama | SF3B4 SAP49 | _____MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFLQA |
| Q15459 | Y456 | Sugiyama | SF3A1 SAP114 | PRWLEQRDRSIREKQsDDEVyAPGLDIESsLKQLAERRtDI |
| Q15527 | Y123 | Sugiyama | SURF2 | GRRYQRALCKYEECQKQGVEyVPACLVHRRRRREDQMDGDG |
| Q15555 | Y268 | Sugiyama | MAPRE2 RP1 | NEQVHsLKLALEGVEKERDFyFGKLREIELLCQEHGQENDD |
| Q15642 | Y590 | Sugiyama | TRIP10 CIP4 STOT STP | MEEDKGDGWTRVRRKEGGEGyVPtsyLRVTLN_________ |
| Q15642 | Y595 | Sugiyama | TRIP10 CIP4 STOT STP | GDGWTRVRRKEGGEGyVPtsyLRVTLN______________ |
| Q15648 | Y1476 | Sugiyama | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | ytPQNLDsEsEsGSSIAEKsyQNsPssDDGIRPLPEYstEK |
| Q15650 | Y345 | Sugiyama | TRIP4 RQT4 | KVTIDFAGRKILEEENsLAEyHSRLDETIQAIANGTLNQPL |
| Q15691 | Y217 | Sugiyama | MAPRE1 | MQQVNVLKLtVEDLEKERDFyFGKLRNIELICQENEGENDP |
| Q15785 | Y54 | Sugiyama | TOMM34 URCC3 | RALRVLQAQGssDPEEEsVLysNRAACHLKDGNCRDCIKDC |
| Q16576 | Y153 | Sugiyama | RBBP7 RBAP46 | PQNPHIIATKtPssDVLVFDyTKHPAKPDPsGECNPDLRLR |
| Q16595 | Y95 | Sugiyama | FXN FRDA X25 | LMNLRKsGtLGHPGsLDEttyERLAEETLDSLAEFFEDLAD |
| Q16719 | Y47 | Sugiyama | KYNU | ERVALHLDEEDKLRHFRECFyIPKIQDLPPVDLSLVNKDEN |
| Q16778 | Y41 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKAMG |
| Q16778 | Y43 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKAMGIM |
| Q53H82 | Y121 | Sugiyama | LACTB2 CGI-83 | IKKLPRNPQREEIIGNGEQQyVyLKDGDVIKTEGATLRVLY |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF3 | Y58 | Sugiyama | HSP90B2P GRP94B GRP94P1 TRAP1 | VTFKSILFVPTFVPRGLFDEyGsKKSDYIKLYVRCVFITDD |
| Q58FF6 | T36 | Sugiyama | HSP90AB4P | LQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPNPR |
| Q58FF6 | Y167 | Sugiyama | HSP90AB4P | GEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIGCL |
| Q58FF6 | Y32 | Sugiyama | HSP90AB4P | KEIFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDII |
| Q58FF7 | T60 | Sugiyama | HSP90AB3P HSP90BC | LQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPNPQ |
| Q58FF7 | Y171 | Sugiyama | HSP90AB3P HSP90BC | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| Q58FF7 | Y492 | Sugiyama | HSP90AB3P HSP90BC | TANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIMETLR |
| Q58FF7 | Y56 | Sugiyama | HSP90AB3P HSP90BC | EEIFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FF8 | T60 | Sugiyama | HSP90AB2P HSP90BB | LWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPNTQ |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q58FF8 | Y261 | Sugiyama | HSP90AB2P HSP90BB | RYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWK |
| Q58FF8 | Y56 | Sugiyama | HSP90AB2P HSP90BB | KEIFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FG0 | Y177 | Sugiyama | HSP90AA5P HSP90AE | GQLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQ |
| Q58FG0 | Y178 | Sugiyama | HSP90AA5P HSP90AE | QLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQK |
| Q5QNW6 | Y41 | Sugiyama | H2BC18 HIST2H2BF | KVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q5QNW6 | Y43 | Sugiyama | H2BC18 HIST2H2BF | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q5T035 | Y67 | Sugiyama | FAM120A2P C9orf129 | SEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERSLPIN |
| Q5T8P6 | Y822 | Sugiyama | RBM26 C13orf10 PRO1777 | KSIKTKTQMQKELLDTELDLyKKMQAGEEVTELRRKYtELQ |
| Q5VTE0 | Y29 | Sugiyama | EEF1A1P5 EEF1AL3 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q5VV41 | Y216 | Sugiyama | ARHGEF16 EPHEXIN4 NBR | KKTLGRKRGHKGsFKDDPQLyQEIQERGLNtsQEsDDDILD |
| Q6DN03 | Y41 | Sugiyama | H2BC20P HIST2H2BC | KAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMG |
| Q6DN03 | Y43 | Sugiyama | H2BC20P HIST2H2BC | QKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMGIM |
| Q6DRA6 | Y41 | Sugiyama | H2BC19P HIST2H2BD | KAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMG |
| Q6DRA6 | Y43 | Sugiyama | H2BC19P HIST2H2BD | QKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMGIM |
| Q6P1L8 | Y51 | Sugiyama | MRPL14 MRPL32 RPML32 | AIQKMTRVRVVDNSALGNsPyHRAPRCIHVYKKNGVGKVGD |
| Q6PKG0 | Y361 | Sugiyama | LARP1 KIAA0731 LARP | GRGRGRGRGRGRGGTRtHFDyQFGyRKFDGVEGPRtPKYMN |
| Q6PKG0 | Y365 | Sugiyama | LARP1 KIAA0731 LARP | GRGRGRGRGGTRtHFDyQFGyRKFDGVEGPRtPKYMNNITY |
| Q6PKG0 | Y633 | Sugiyama | LARP1 KIAA0731 LARP | MEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPHyM |
| Q6PKG0 | Y699 | Sugiyama | LARP1 KIAA0731 LARP | INDGLFyyEQDLWAEKFEPEysQIKQEVENFKKVNMISREQ |
| Q6S8J3 | S1065 | Sugiyama | POTEE A26C1A POTE2 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6S8J3 | Y1062 | Sugiyama | POTEE A26C1A POTE2 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6VEQ5 | Y103 | Sugiyama | WASH2P FAM39B | KKAIKVFSSAKYPAPERLQEyGsIFTGAQDPGLQRRPRHRI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q71U36 | T94 | Sugiyama | TUBA1A TUBA3 | VIDEVRtGtyRQLFHPEQLItGKEDAANNyARGHYTIGKEI |
| Q71U36 | Y103 | Sugiyama | TUBA1A TUBA3 | yRQLFHPEQLItGKEDAANNyARGHYTIGKEIIDLVLDRIR |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q7Z5J4 | Y305 | Sugiyama | RAI1 KIAA1820 | QQQQQQQALQSRHHAQETLHyQNLAKYQHYGQQGQGYCQPD |
| Q7Z5K2 | Y452 | Sugiyama | WAPL FOE KIAA0261 WAPAL | EDHEtGGDEGGsGsSNYKIKyFGFDDLsEsEDDEDDDCQVE |
| Q86UK7 | Y306 | Sugiyama | ZNF598 | QFSYAPRHSRRNEGVVGGEDyEEVDRysRQGRVARAGTRGA |
| Q86V81 | Y250 | Sugiyama | ALYREF ALY BEF THOC4 | AGRNSKQQLsAEELDAQLDAyNARMDts_____________ |
| Q86VS8 | Y171 | Sugiyama | HOOK3 | MTAIQELMSKEsPVSAGNDAyVDLDRQLKKTTEELNEALSA |
| Q8IWX8 | Y894 | Sugiyama | CHERP DAN26 SCAF6 | GDVRDKWDQYKGVGVALDDPyENyRRNKsysFIARMKARDE |
| Q8IWX8 | Y897 | Sugiyama | CHERP DAN26 SCAF6 | RDKWDQYKGVGVALDDPyENyRRNKsysFIARMKARDECK_ |
| Q8N0Y7 | S134 | Sugiyama | PGAM4 PGAM3 | IWRRsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSYE |
| Q8N0Y7 | Y119 | Sugiyama | PGAM4 PGAM3 | NKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsKD |
| Q8N0Y7 | Y133 | Sugiyama | PGAM4 PGAM3 | KIWRRsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSY |
| Q8N257 | Y41 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | KAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKAMG |
| Q8N257 | Y43 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | QKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKAMGIM |
| Q8NBS9 | Y251 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | ALGLEHSETVKIGKVDCtQHyELCsGNQVRGyPtLLWFRDG |
| Q8ND04 | Y631 | Sugiyama | SMG8 ABC2 C17orf71 | CNCGRKQAPRDDPFDIKAANyDFyQLLEEKCCGKLDHINFP |
| Q8ND04 | Y634 | Sugiyama | SMG8 ABC2 C17orf71 | GRKQAPRDDPFDIKAANyDFyQLLEEKCCGKLDHINFPVFE |
| Q8ND56 | Y455 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | RGFRGGFRGGRGGREFADFEyRKTTAFGP____________ |
| Q8NFI4 | Y185 | Sugiyama | ST13P5 FAM10A5 | NAAIQDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEAAHDL |
| Q8NHW5 | Y13 | Sugiyama | RPLP0P6 | ________MPREDRATWKSNyFLKIIQLLDDyPKCFIVGAD |
| Q8NHW5 | Y24 | Sugiyama | RPLP0P6 | EDRATWKSNyFLKIIQLLDDyPKCFIVGADNVGsKQMQQIR |
| Q8NI22 | Y135 | Sugiyama | MCFD2 SDNSF | DELINIIDGVLRDDDKNNDGyIDyAEFAKSLQ_________ |
| Q8NI22 | Y138 | Sugiyama | MCFD2 SDNSF | INIIDGVLRDDDKNNDGyIDyAEFAKSLQ____________ |
| Q8TAE8 | Y166 | Sugiyama | GADD45GIP1 MRPL59 PLINP1 PRG6 | AQADKERRARLQAEAQELLGyQVDPRSARFQELLQDLEKKE |
| Q8TEW0 | Y388 | Sugiyama | PARD3 PAR3 PAR3A | QLSQSEKNNyyssRFsPDsQyIDNRSVNSAGLHTVQRAPRL |
| Q8WUA2 | Y401 | Sugiyama | PPIL4 | TSKKHKKKTHHCsEEKEDEDyMPIKNTNQDIYREMGFGHYE |
| Q92526 | Y109 | Sugiyama | CCT6B | GDGTTSNVLIIGELLKQADLyISEGLHPRIIAEGFEAAKIK |
| Q92598 | Y641 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | MIMQDKLEKERNDAKNAVEEyVyEFRDKLCGPYEKFICEQD |
| Q92598 | Y643 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | MQDKLEKERNDAKNAVEEyVyEFRDKLCGPYEKFICEQDHQ |
| Q92598 | Y688 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | LLTETEDWLyEEGEDQAKQAyVDKLEELMKIGTPVKVRFQE |
| Q92620 | Y222 | Sugiyama | DHX38 DDX38 KIAA0224 PRP16 | HRPKDAAtPSRSTWEEEDsGyGSSRRSQWEsPsPTPSYRDS |
| Q92785 | Y172 | Sugiyama | DPF2 BAF45D REQ UBID4 | RARKRILEPDDFLDDLDDEDyEEDtPKRRGKGKSKGKGVGS |
| Q93079 | Y41 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q93079 | Y43 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q96C90 | S32 | Sugiyama | PPP1R14B PLCB3N PNG | LAAPAPGPGsGGPGPRVyFQsPPGAAGEGPGGADDEGPVRR |
| Q96C90 | Y29 | Sugiyama | PPP1R14B PLCB3N PNG | GAALAAPAPGPGsGGPGPRVyFQsPPGAAGEGPGGADDEGP |
| Q96CT7 | Y38 | Sugiyama | CCDC124 | RRAEAKAAADAKKQKELEDAyWKDDDKHVMRKEQRKEEKEK |
| Q96CW6 | Y300 | Sugiyama | SLC7A6OS | GSSRQRMWSKYPLDVQKEFGyDsPHDLDsD___________ |
| Q96D46 | Y459 | Sugiyama | NMD3 CGI-07 | YQDFLEDLEEDEAIRKNVNIyRDsAIPVEsDtDDEGAPRIS |
| Q96GA3 | Y66 | Sugiyama | LTV1 C6orf93 | IDNEERRAEQRKyGVFFDDDyDyLQHLKEPSGPSELIPSST |
| Q96GA3 | Y68 | Sugiyama | LTV1 C6orf93 | NEERRAEQRKyGVFFDDDyDyLQHLKEPSGPSELIPSSTFS |
| Q96GX9 | Y57 | Sugiyama | APIP CGI-29 | HLGWVTGTGGGISLKHGDEIyIAPsGVQKERIQPEDMFVCD |
| Q96HY6 | Y189 | Sugiyama | DDRGK1 C20orf116 UFBP1 | QKEEEERKAREEQAQREHEEyLKLKEAFVVEEEGVGETMTE |
| Q96NB3 | Y315 | Sugiyama | ZNF830 CCDC16 | EDEEGRLDRQIGEIDEQIECyRRVEKLRNRQDEIKNKLKEI |
| Q96QK1 | Y507 | Sugiyama | VPS35 MEM3 TCCCTA00141 | EQSLVGRFIHLLRsEDPDQQyLILNTARKHFGAGGNQRIRF |
| Q99426 | Y107 | Sugiyama | TBCB CG22 CKAP1 | VIDHsGARLGEyEDVSRVEKytIsQEAyDQRQDtVRSFLKR |
| Q99426 | Y114 | Sugiyama | TBCB CG22 CKAP1 | RLGEyEDVSRVEKytIsQEAyDQRQDtVRSFLKRsKLGRyN |
| Q99470 | Y187 | Sugiyama | SDF2 | GRPISGQKEVHGMAQPSQNNyWKAMEGIFMKPSELLKAEAH |
| Q99543 | S275 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | RAQRKKEEMNRIRtLVDNAysCDPRIKKFKEEEKAKKEAEK |
| Q99543 | Y137 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | KHHPDKRKAAGEPIKEGDNDyFTCITKAYEMLSDPVKRRAF |
| Q99543 | Y274 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | TRAQRKKEEMNRIRtLVDNAysCDPRIKKFKEEEKAKKEAE |
| Q99613 | Y881 | Sugiyama | EIF3C EIF3S8 | EKLGsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMRR |
| Q99614 | S281 | Sugiyama | TTC1 TPR1 | PFGLstENFQIKQDsstGsysINFVQNPNNNR_________ |
| Q99614 | Y96 | Sugiyama | TTC1 TPR1 | ADKVENKsNEDVNssELDEEyLIELEKNMSDEEKQKRREES |
| Q99733 | Y85 | Sugiyama | NAP1L4 NAP2 | RRINALKQLQVRCAHIEAKFyEEVHDLERKyAALyQPLFDK |
| Q99848 | Y265 | Sugiyama | EBNA1BP2 EBP2 | NQKFGFGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPG |
| Q99877 | Y41 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99877 | Y43 | Sugiyama | H2BC15 H2BFD HIST1H2BN | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99879 | Y41 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99879 | Y43 | Sugiyama | H2BC14 H2BFE HIST1H2BM | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99880 | Y41 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99880 | Y43 | Sugiyama | H2BC13 H2BFC HIST1H2BL | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BQE3 | T94 | Sugiyama | TUBA1C TUBA6 | VIDEVRtGtyRQLFHPEQLItGKEDAANNyARGHYTIGKEI |
| Q9BQE3 | Y103 | Sugiyama | TUBA1C TUBA6 | yRQLFHPEQLItGKEDAANNyARGHYTIGKEIIDLVLDRIR |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BQE3 | Y449 | Sugiyama | TUBA1C TUBA6 | EKDyEEVGADsADGEDEGEEy____________________ |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BRK5 | Y162 | Sugiyama | SDF4 CAB45 PSEC0034 | sKTHFRAVDPDGDGHVsWDEyKVKFLASKGHSEKEVADAIR |
| Q9BRK5 | Y342 | Sugiyama | SDF4 CAB45 PSEC0034 | MIAVADENQNHHLEPEEVLKysEFFTGSKLVDYARsVHEEF |
| Q9BRL6 | Y44 | Sugiyama | SRSF8 SFRS2B SRP46 | RtsPDsLRRVFEKYGRVGDVyIPREPHTKAPRGFAFVRFHD |
| Q9BS40 | Y20 | Sugiyama | LXN | _MEIPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQA |
| Q9BS40 | Y23 | Sugiyama | LXN | IPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQAsME |
| Q9BSU3 | Y145 | Sugiyama | NAA11 ARD1B ARD2 | TLNFQISEVEPKyyADGEDAyAMKRDLSQMADELRRQMDLK |
| Q9BVA1 | T107 | Sugiyama | TUBB2B | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q9BVA1 | Y106 | Sugiyama | TUBB2B | RPDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESES |
| Q9BWG6 | Y193 | Sugiyama | SCNM1 | sAtVsAPAPMsPtRRRALDHyLTLRSsGWIPDGRGRWVKDE |
| Q9BXP5 | Y864 | Sugiyama | SRRT ARS2 ASR2 | GYPGKPRNRMVRGDPRAIVEyRDLDAPDDVDFF________ |
| Q9BXS5 | Y418 | Sugiyama | AP1M1 CLTNM | IEKSGYQALPWVRYITQNGDyQLRtQ_______________ |
| Q9BY32 | S53 | Sugiyama | ITPA C20orf37 My049 OK/SW-cl.9 | CTLVAQKIDLPEyQGEPDEIsIQKCQEAVRQVQGPVLVEDT |
| Q9BY32 | Y45 | Sugiyama | ITPA C20orf37 My049 OK/SW-cl.9 | QILGDKFPCTLVAQKIDLPEyQGEPDEIsIQKCQEAVRQVQ |
| Q9BYX7 | S365 | Sugiyama | POTEKP ACTBL3 FKSG30 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BYX7 | Y362 | Sugiyama | POTEKP ACTBL3 FKSG30 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q9BZI7 | Y160 | Sugiyama | UPF3B RENT3B UPF3X | AKKKTKKRDTKVGtIDDDPEyRKFLEsyAtDNEKMTstPEt |
| Q9BZI7 | Y167 | Sugiyama | UPF3B RENT3B UPF3X | RDTKVGtIDDDPEyRKFLEsyAtDNEKMTstPEtLLEEIEA |
| Q9BZZ5 | Y28 | Sugiyama | API5 MIG8 | YRNyGILADATEQVGQHKDAyQVILDGVKGGTKEKRLAAQF |
| Q9H1E3 | S149 | Sugiyama | NUCKS1 NUCKS JC7 | DsGsDEDFLMEDDDDsDyGSsKKKNKKMVKKSKPERKEKKM |
| Q9H1E3 | Y146 | Sugiyama | NUCKS1 NUCKS JC7 | QEKDsGsDEDFLMEDDDDsDyGSsKKKNKKMVKKSKPERKE |
| Q9H1E3 | Y26 | Sugiyama | NUCKS1 NUCKS JC7 | RNRKVVDysQFQEsDDADEDyGRDsGPPtKKIRSsPREAKN |
| Q9H2H8 | Y75 | Sugiyama | PPIL3 | DPTGTGRGGNSIWGKKFEDEysEyLKHNVRGVVSMANNGPN |
| Q9H2H8 | Y78 | Sugiyama | PPIL3 | GTGRGGNSIWGKKFEDEysEyLKHNVRGVVSMANNGPNTNG |
| Q9H814 | Y152 | Sugiyama | PHAX RNUXA | TELGILGMEGTIDRsRQsEtyNyLLAKKLRKESQEHTKDLD |
| Q9H814 | Y154 | Sugiyama | PHAX RNUXA | LGILGMEGTIDRsRQsEtyNyLLAKKLRKESQEHTKDLDKE |
| Q9HAP6 | Y118 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | KTDEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLKRGD |
| Q9HCN8 | Y81 | Sugiyama | SDF2L1 UNQ1941/PRO4424 | GSGSGQQSVtGVEAsDDANSyWRIRGGSEGGCPRGSPVRCG |
| Q9NQA3 | Y85 | Sugiyama | WASH6P CXYorf1 FAM39A | KKAIKVFSSAKYPAPERLQEyGsIFTGAQDPGLQRRPRHRI |
| Q9NR56 | Y68 | Sugiyama | MBNL1 EXP KIAA0428 MBNL | GRVIACFDsLKGRCSRENCKyLHPPPHLKTQLEINGRNNLI |
| Q9NRX4 | Y52 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | RSGAPAAESKEIVRGYKWAEyHADIyDKVSGDMQKQGCDCE |
| Q9NRX4 | Y57 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | AAESKEIVRGYKWAEyHADIyDKVSGDMQKQGCDCECLGGG |
| Q9NUK0 | Y69 | Sugiyama | MBNL3 CHCR MBLX39 MBXL | GRVVACFDSLKGRCTRENCKyLHPPPHLKTQLEINGRNNLI |
| Q9NUP9 | Y118 | Sugiyama | LIN7C MALS3 VELI3 | KTEEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLKRGD |
| Q9NVD7 | Y124 | Sugiyama | PARVA MXRA2 | WINDVLVGERIIVKDLAEDLyDGQVLQKLFEKLESEKLNVA |
| Q9NVS9 | Y157 | Sugiyama | PNPO | NRQVRVEGPVKKLPEEEAECyFHSRPKssQIGAVVSHQSSV |
| Q9NVS9 | Y256 | Sugiyama | PNPO | LPtGDsPLGPMTHRGEEDWLyERLAP_______________ |
| Q9NW13 | Y737 | Sugiyama | RBM28 | SRKKAKGNKTETRFNQLVEQyKQKLLGPSKGAPLAKRSKWF |
| Q9NY12 | Y145 | Sugiyama | GAR1 NOLA1 | FSVKLSENMKASSFKKLQKFyIDPyKLLPLQRFLPRPPGEK |
| Q9NY12 | Y149 | Sugiyama | GAR1 NOLA1 | LSENMKASSFKKLQKFyIDPyKLLPLQRFLPRPPGEKGPPR |
| Q9NY65 | T94 | Sugiyama | TUBA8 TUBAL2 | VVDEVRAGTYRQLFHPEQLItGKEDAANNyARGHYTVGKES |
| Q9NY65 | Y103 | Sugiyama | TUBA8 TUBAL2 | YRQLFHPEQLItGKEDAANNyARGHYTVGKESIDLVLDRIR |
| Q9NYF8 | Y219 | Sugiyama | BCLAF1 BTF KIAA0164 | IDEFNKssAtsGDIWPGLsAyDNsPRsPHsPsPIAtPPSQS |
| Q9NYF8 | Y408 | Sugiyama | BCLAF1 BTF KIAA0164 | EsGKQKFNDsEGDDtEEtEDyRQFRKsVLADQGKsFATAsH |
| Q9NYU2 | Y1516 | Sugiyama | UGGT1 GT UGCGL1 UGGT UGT1 UGTR | PMTKEPKLEAAVRIVPEWQDyDQEIKQLQIRFQKEKETGAL |
| Q9NYU2 | Y966 | Sugiyama | UGGT1 GT UGCGL1 UGGT UGT1 UGTR | LVMKVDALLsAQPKGDPRIEyQFFEDRHSAIKLRPKEGETY |
| Q9NZB2 | Y418 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | SEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERssPIN |
| Q9UBS4 | Y74 | Sugiyama | DNAJB11 EDJ ERJ3 HDJ9 PSEC0121 UNQ537/PRO1080 | PDRNPDDPQAQEKFQDLGAAyEVLsDSEKRKQyDTyGEEGL |
| Q9UHI6 | Y659 | Sugiyama | DDX20 DP103 GEMIN3 | RVPVLASSsQsGDsEsDSDSySSRTSSQSKGNKsyLEGssD |
| Q9UHX1 | Y269 | Sugiyama | PUF60 FIR ROBPI SIAHBP1 | FGKIKSCTLARDPTTGKHKGyGFIEyEKAQSSQDAVSSMNL |
| Q9UHX1 | Y274 | Sugiyama | PUF60 FIR ROBPI SIAHBP1 | SCTLARDPTTGKHKGyGFIEyEKAQSSQDAVSSMNLFDLGG |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UII2 | Y58 | Sugiyama | ATP5IF1 ATPI ATPIF1 | GsIREAGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEI |
| Q9UIQ6 | Y70 | Sugiyama | LNPEP OTASE | GsRLLVRGLGEHEMEEDEEDyEssAKLLGMsFMNRssGLRN |
| Q9UKV3 | Y1086 | Sugiyama | ACIN1 ACINUS KIAA0670 | RTALHGVKWPQSNPKFLCADyAEQDELDyHRGLLVDRPsEt |
| Q9UKV3 | Y1094 | Sugiyama | ACIN1 ACINUS KIAA0670 | WPQSNPKFLCADyAEQDELDyHRGLLVDRPsEtKTEEQGIP |
| Q9UMX5 | Y65 | Sugiyama | NENF CIR2 SPUF | RLFtEEELARYGGEEEDQPIyLAVKGVVFDVtSGKEFYGRG |
| Q9UNH7 | Y220 | Sugiyama | SNX6 | VSGVKDVDDFFEHERTFLLEyHNRVKDASAKSDRMTRSHKS |
| Q9UNZ2 | Y167 | Sugiyama | NSFL1C UBXN2C | PRPFAGGGYRLGAAPEEEsAyVAGEKRQHssQDVHVVLKLW |
| Q9UPY6 | Y151 | Sugiyama | WASF3 KIAA0900 SCAR3 WAVE3 | PPPLNILTPYRDDKKDGLKFyTDPsyFFDLWKEKMLQDTED |
| Q9UPY6 | Y156 | Sugiyama | WASF3 KIAA0900 SCAR3 WAVE3 | ILTPYRDDKKDGLKFyTDPsyFFDLWKEKMLQDTEDKRKEK |
| Q9UQ80 | S383 | Sugiyama | PA2G4 EBP1 | sRKtQKKKKKKAsKtAENAtsGEtLEENEAGD_________ |
| Q9UQ80 | Y98 | Sugiyama | PA2G4 EBP1 | TSISVNNCVCHFsPLKSDQDyILKEGDLVKIDLGVHVDGFI |
| Q9Y230 | Y446 | Sugiyama | RUVBL2 INO80J TIP48 TIP49B CGI-46 | IKRVysLFLDEsRSTQYMKEyQDAFLFNELKGEtMDTS___ |
| Q9Y237 | S72 | Sugiyama | PIN4 | MEAMEKLKSGMRFNEVAAQysEDKARQGGDLGWMTRGSMVG |
| Q9Y2B0 | Y71 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | IQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEICDRMKE |
| Q9Y2B0 | Y92 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | ARsEAHLtELLEEICDRMKEyGEQIDPstHRKNYVRVVGRN |
| Q9Y2T7 | Y107 | Sugiyama | YBX2 CSDA3 MSY2 | KPVLAIQVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| Q9Y2W1 | T230 | Sugiyama | THRAP3 BCLAF2 TRAP150 | tsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERsPA |
| Q9Y2W1 | Y228 | Sugiyama | THRAP3 BCLAF2 TRAP150 | GGtsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERs |
| Q9Y3D8 | Y31 | Sugiyama | AK6 CINAP AD-004 CGI-137 | TPGVGKTTLGKELASKSGLKyINVGDLAREEQLYDGYDEEY |
| Q9Y3F4 | Y114 | Sugiyama | STRAP MAWD UNRIP | LMTLAHKHIVKtVDFtQDSNyLLtGGQDKLLRIYDLNKPEA |
| Q9Y3U8 | Y5 | Sugiyama | RPL36 | ________________MALRyPMAVGLNKGHKVTKNVSKPR |
| Q9Y3U8 | Y53 | Sugiyama | RPL36 | LTKHTKFVRDMIREVCGFAPyERRAMELLKVSKDKRALKFI |
| Q9Y450 | Y58 | Sugiyama | HBS1L HBS1 KIAA1038 | AQFIYSRRDKPsVEPVEEyDyEDLKEssNsVsNHQLSGFDQ |
| Q9Y490 | Y1893 | Sugiyama | TLN1 KIAA1027 TLN | TKsNtsPEELGPLANQLTsDyGRLAsEAKPAAVAAENEEIG |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y5S9 | Y54 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KRKGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWI |
| Q9Y639 | Y216 | Sugiyama | NPTN SDFR1 SDR1 | KNASNMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKA |
| Q9Y639 | Y220 | Sugiyama | NPTN SDFR1 SDR1 | NMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKAAPDI |
| Q9Y696 | Y244 | Sugiyama | CLIC4 | AysRDEFtNtCPsDKEVEIAysDVAKRLTK___________ |
| Q9Y6W5 | Y150 | Sugiyama | WASF2 WAVE2 | PPPLNNLTPYRDDGKEALKFyTDPsyFFDLWKEKMLQDTKD |
| Q9Y6W5 | Y155 | Sugiyama | WASF2 WAVE2 | NLTPYRDDGKEALKFyTDPsyFFDLWKEKMLQDTKDIMKEK |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.247367e-10 | 9.648 | 1 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.545784e-08 | 7.256 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.207393e-07 | 6.283 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 5.294193e-07 | 6.276 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.439204e-06 | 5.842 | 1 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.893593e-06 | 5.723 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.720557e-06 | 5.565 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.461518e-06 | 5.351 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.173215e-06 | 5.088 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 9.824894e-06 | 5.008 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.425117e-05 | 4.846 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.342039e-05 | 4.872 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.577459e-05 | 4.802 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 1.745468e-05 | 4.758 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.899822e-05 | 4.721 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.907435e-05 | 4.720 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 2.339580e-05 | 4.631 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 3.003620e-05 | 4.522 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.267302e-05 | 4.486 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 3.796243e-05 | 4.421 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.876088e-05 | 4.412 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.245098e-05 | 4.372 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 6.331693e-05 | 4.198 | 1 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.031978e-05 | 4.153 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 8.538951e-05 | 4.069 | 1 | 1 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.872165e-05 | 4.052 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 9.156514e-05 | 4.038 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 9.001981e-05 | 4.046 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 9.595701e-05 | 4.018 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 9.990622e-05 | 4.000 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.344357e-04 | 3.871 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.488944e-04 | 3.827 | 1 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.573901e-04 | 3.803 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.654874e-04 | 3.781 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 1.845013e-04 | 3.734 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.845013e-04 | 3.734 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.025036e-04 | 3.694 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.223353e-04 | 3.653 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.550300e-04 | 3.593 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.656603e-04 | 3.576 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.760634e-04 | 3.559 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.910436e-04 | 3.536 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 3.138647e-04 | 3.503 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 3.305667e-04 | 3.481 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.959415e-04 | 3.402 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.959415e-04 | 3.402 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.737921e-04 | 3.427 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 3.959415e-04 | 3.402 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 4.156213e-04 | 3.381 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.209142e-04 | 3.376 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.991588e-04 | 3.302 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.876298e-04 | 3.231 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.365737e-04 | 3.196 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.210699e-04 | 3.142 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.581695e-04 | 3.066 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.692314e-04 | 3.061 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 8.581695e-04 | 3.066 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 8.822569e-04 | 3.054 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 9.522400e-04 | 3.021 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.072031e-03 | 2.970 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.072031e-03 | 2.970 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.072031e-03 | 2.970 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.249191e-03 | 2.903 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.258208e-03 | 2.900 | 0 | 0 |
| TRKA activation by NGF | R-HSA-187042 | 1.368895e-03 | 2.864 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.368895e-03 | 2.864 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.354960e-03 | 2.868 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.460405e-03 | 2.836 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 1.567966e-03 | 2.805 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.601373e-03 | 2.796 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.957447e-03 | 2.708 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 1.957447e-03 | 2.708 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.788809e-03 | 2.747 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 1.957447e-03 | 2.708 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.028143e-03 | 2.693 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.028143e-03 | 2.693 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.053810e-03 | 2.687 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.322170e-03 | 2.634 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.645719e-03 | 2.577 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 2.645719e-03 | 2.577 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.564355e-03 | 2.591 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.564355e-03 | 2.591 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.645719e-03 | 2.577 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.489205e-03 | 2.604 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.713997e-03 | 2.566 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.039536e-03 | 2.517 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.039536e-03 | 2.517 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 3.431549e-03 | 2.465 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.240019e-03 | 2.489 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.449332e-03 | 2.462 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.180530e-03 | 2.498 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 3.519734e-03 | 2.453 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.880244e-03 | 2.411 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.262456e-03 | 2.370 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 4.262456e-03 | 2.370 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 4.312812e-03 | 2.365 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 4.375471e-03 | 2.359 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 5.287414e-03 | 2.277 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.287414e-03 | 2.277 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 5.093465e-03 | 2.293 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 5.287414e-03 | 2.277 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.666744e-03 | 2.331 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.900767e-03 | 2.310 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.542957e-03 | 2.256 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 6.015537e-03 | 2.221 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 6.067412e-03 | 2.217 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.353295e-03 | 2.197 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 6.353295e-03 | 2.197 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.353295e-03 | 2.197 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 6.353295e-03 | 2.197 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.714432e-03 | 2.173 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.031151e-03 | 2.153 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 7.574733e-03 | 2.121 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.142108e-03 | 2.089 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.768111e-03 | 2.110 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 7.508431e-03 | 2.124 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 8.734695e-03 | 2.059 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 8.142108e-03 | 2.089 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 8.750825e-03 | 2.058 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 8.750825e-03 | 2.058 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 8.750825e-03 | 2.058 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 9.993193e-03 | 2.000 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.993193e-03 | 2.000 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.007851e-02 | 1.997 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.007851e-02 | 1.997 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.007851e-02 | 1.997 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.091040e-02 | 1.962 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.135178e-02 | 1.945 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.148957e-02 | 1.940 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.156409e-02 | 1.937 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.290376e-02 | 1.889 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.298209e-02 | 1.887 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.298209e-02 | 1.887 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.298209e-02 | 1.887 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.604011e-02 | 1.795 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.551855e-02 | 1.809 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.437426e-02 | 1.842 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.519422e-02 | 1.818 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.522055e-02 | 1.818 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 1.620408e-02 | 1.790 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.620408e-02 | 1.790 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.620408e-02 | 1.790 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.727003e-02 | 1.763 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.792990e-02 | 1.746 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.792990e-02 | 1.746 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.792990e-02 | 1.746 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.792990e-02 | 1.746 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.823258e-02 | 1.739 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.873414e-02 | 1.727 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.873414e-02 | 1.727 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.113722e-02 | 1.675 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 2.113722e-02 | 1.675 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.166369e-02 | 1.664 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.089105e-02 | 1.680 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.968444e-02 | 1.706 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.066095e-02 | 1.685 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.066095e-02 | 1.685 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.066095e-02 | 1.685 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.972988e-02 | 1.705 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.972988e-02 | 1.705 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.066095e-02 | 1.685 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.269268e-02 | 1.644 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 2.354538e-02 | 1.628 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.972988e-02 | 1.705 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.357968e-02 | 1.627 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.457149e-02 | 1.610 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.303325e-02 | 1.638 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.555746e-02 | 1.592 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.555746e-02 | 1.592 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 2.555746e-02 | 1.592 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.565779e-02 | 1.591 | 0 | 0 |
| Disease | R-HSA-1643685 | 2.588828e-02 | 1.587 | 1 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.663810e-02 | 1.574 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.717225e-02 | 1.566 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.763688e-02 | 1.559 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.771346e-02 | 1.557 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.853614e-02 | 1.545 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.882063e-02 | 1.540 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.970227e-02 | 1.527 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.111382e-02 | 1.507 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 3.153865e-02 | 1.501 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 3.153865e-02 | 1.501 | 0 | 0 |
| NTF3 activates NTRK2 (TRKB) signaling | R-HSA-9025046 | 4.183019e-02 | 1.379 | 0 | 0 |
| NTF4 activates NTRK2 (TRKB) signaling | R-HSA-9026357 | 4.183019e-02 | 1.379 | 0 | 0 |
| BDNF activates NTRK2 (TRKB) signaling | R-HSA-9024909 | 4.183019e-02 | 1.379 | 0 | 0 |
| NTF3 activates NTRK3 signaling | R-HSA-9034013 | 4.183019e-02 | 1.379 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.426284e-02 | 1.465 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.426284e-02 | 1.465 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.426284e-02 | 1.465 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.898743e-02 | 1.409 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.414186e-02 | 1.467 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.898743e-02 | 1.409 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 4.238421e-02 | 1.373 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 3.659544e-02 | 1.437 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 4.183019e-02 | 1.379 | 1 | 1 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.659544e-02 | 1.437 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.707821e-02 | 1.431 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.426284e-02 | 1.465 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.570582e-02 | 1.447 | 1 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.983736e-02 | 1.400 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 3.659544e-02 | 1.437 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.426284e-02 | 1.465 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.964720e-02 | 1.402 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.964720e-02 | 1.402 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 3.659544e-02 | 1.437 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.217781e-02 | 1.375 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.818078e-02 | 1.418 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.707821e-02 | 1.431 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.989034e-02 | 1.399 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 3.186732e-02 | 1.497 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.269783e-02 | 1.370 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.289686e-02 | 1.368 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.394359e-02 | 1.357 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.394359e-02 | 1.357 | 1 | 1 |
| Long-term potentiation | R-HSA-9620244 | 4.394359e-02 | 1.357 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 4.416576e-02 | 1.355 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.650481e-02 | 1.333 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.674595e-02 | 1.330 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.711897e-02 | 1.327 | 1 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 4.871868e-02 | 1.312 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.971613e-02 | 1.304 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.131715e-02 | 1.290 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 5.142522e-02 | 1.289 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.178635e-02 | 1.286 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.178635e-02 | 1.286 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 5.201300e-02 | 1.284 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 5.201300e-02 | 1.284 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.201300e-02 | 1.284 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.201300e-02 | 1.284 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 5.201300e-02 | 1.284 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 5.201300e-02 | 1.284 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 5.201300e-02 | 1.284 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 5.201300e-02 | 1.284 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.349223e-02 | 1.272 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.450388e-02 | 1.264 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 6.208821e-02 | 1.207 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 6.208821e-02 | 1.207 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 7.205696e-02 | 1.142 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 7.205696e-02 | 1.142 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 7.205696e-02 | 1.142 | 1 | 1 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 8.192037e-02 | 1.087 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 8.192037e-02 | 1.087 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 8.192037e-02 | 1.087 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 8.192037e-02 | 1.087 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.909158e-02 | 1.161 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.727074e-02 | 1.242 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.585409e-02 | 1.181 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 6.208821e-02 | 1.207 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 7.854931e-02 | 1.105 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.102569e-02 | 1.091 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.179904e-02 | 1.144 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.585409e-02 | 1.181 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.725061e-02 | 1.242 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.483457e-02 | 1.126 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 6.208821e-02 | 1.207 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 8.192037e-02 | 1.087 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 6.008561e-02 | 1.221 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.483457e-02 | 1.126 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 7.661429e-02 | 1.116 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.909158e-02 | 1.161 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.294716e-02 | 1.201 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 7.205696e-02 | 1.142 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 8.192037e-02 | 1.087 | 1 | 1 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.585409e-02 | 1.181 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.585409e-02 | 1.181 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.530298e-02 | 1.123 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 7.205696e-02 | 1.142 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 8.192037e-02 | 1.087 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 8.192037e-02 | 1.087 | 1 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 6.585409e-02 | 1.181 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.880514e-02 | 1.162 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 6.546354e-02 | 1.184 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 7.791051e-02 | 1.108 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.033007e-02 | 1.219 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 7.647639e-02 | 1.116 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.008561e-02 | 1.221 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.727074e-02 | 1.242 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 6.585409e-02 | 1.181 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 6.585409e-02 | 1.181 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.294716e-02 | 1.201 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 9.167954e-02 | 1.038 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 9.167954e-02 | 1.038 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 9.167954e-02 | 1.038 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 1.013356e-01 | 0.994 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 1.013356e-01 | 0.994 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.013356e-01 | 0.994 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.013356e-01 | 0.994 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.108895e-01 | 0.955 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.108895e-01 | 0.955 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 1.108895e-01 | 0.955 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.108895e-01 | 0.955 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.108895e-01 | 0.955 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.203425e-01 | 0.920 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.203425e-01 | 0.920 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.296956e-01 | 0.887 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.389497e-01 | 0.857 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.389497e-01 | 0.857 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.389497e-01 | 0.857 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.389497e-01 | 0.857 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.481061e-01 | 0.829 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.481061e-01 | 0.829 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.571656e-01 | 0.804 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.571656e-01 | 0.804 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.571656e-01 | 0.804 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.571656e-01 | 0.804 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.571656e-01 | 0.804 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.571656e-01 | 0.804 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.571656e-01 | 0.804 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.661294e-01 | 0.780 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.417891e-02 | 1.075 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.353084e-01 | 0.869 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.389272e-01 | 0.857 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.425669e-01 | 0.846 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.499062e-01 | 0.824 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.648009e-01 | 0.783 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 1.013356e-01 | 0.994 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 9.714972e-02 | 1.013 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 1.108895e-01 | 0.955 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.038732e-02 | 1.044 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.881772e-02 | 1.052 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.881772e-02 | 1.052 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.881772e-02 | 1.052 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.605806e-01 | 0.794 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.203425e-01 | 0.920 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 9.167954e-02 | 1.038 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.571656e-01 | 0.804 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 1.661294e-01 | 0.780 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.689632e-02 | 1.014 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.108895e-01 | 0.955 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 1.296956e-01 | 0.887 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.389497e-01 | 0.857 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 1.481061e-01 | 0.829 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.481061e-01 | 0.829 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.481061e-01 | 0.829 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.571656e-01 | 0.804 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.571656e-01 | 0.804 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 9.059497e-02 | 1.043 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.415091e-01 | 0.849 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.027611e-01 | 0.988 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 1.536040e-01 | 0.814 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.462269e-01 | 0.835 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.661294e-01 | 0.780 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.038345e-01 | 0.984 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.059497e-02 | 1.043 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.059497e-02 | 1.043 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.689632e-02 | 1.014 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.106410e-01 | 0.956 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 1.013356e-01 | 0.994 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 1.013356e-01 | 0.994 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 1.481061e-01 | 0.829 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 1.571656e-01 | 0.804 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.140874e-01 | 0.943 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.573196e-01 | 0.803 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.389272e-01 | 0.857 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.499062e-01 | 0.824 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.122527e-01 | 0.950 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 1.571656e-01 | 0.804 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.571656e-01 | 0.804 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.261034e-01 | 0.899 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.215655e-02 | 1.035 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 1.013356e-01 | 0.994 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.203425e-01 | 0.920 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.296956e-01 | 0.887 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.481061e-01 | 0.829 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.571656e-01 | 0.804 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.571656e-01 | 0.804 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.714972e-02 | 1.013 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.046085e-01 | 0.980 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 8.448129e-02 | 1.073 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.421708e-01 | 0.847 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 1.389497e-01 | 0.857 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.571656e-01 | 0.804 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.571656e-01 | 0.804 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.571656e-01 | 0.804 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.648009e-01 | 0.783 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.736905e-02 | 1.059 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.077441e-01 | 0.968 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.077737e-01 | 0.967 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.499062e-01 | 0.824 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.072231e-01 | 0.970 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.072231e-01 | 0.970 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.203425e-01 | 0.920 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.203425e-01 | 0.920 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.004764e-01 | 0.998 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 1.281376e-01 | 0.892 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.017430e-01 | 0.992 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.000819e-01 | 1.000 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 8.702737e-02 | 1.060 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.203425e-01 | 0.920 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 9.038732e-02 | 1.044 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.586593e-01 | 0.800 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.108895e-01 | 0.955 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 1.332493e-01 | 0.875 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.100043e-01 | 0.959 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.284696e-01 | 0.891 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 8.650019e-02 | 1.063 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.137228e-01 | 0.944 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.356641e-02 | 1.029 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.168020e-01 | 0.933 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.332493e-01 | 0.875 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.714972e-02 | 1.013 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.245872e-01 | 0.905 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.389497e-01 | 0.857 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.648009e-01 | 0.783 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.648009e-01 | 0.783 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.648009e-01 | 0.783 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.648009e-01 | 0.783 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.648009e-01 | 0.783 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.658229e-01 | 0.780 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.140874e-01 | 0.943 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.418961e-02 | 1.075 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.995121e-02 | 1.046 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.648009e-01 | 0.783 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.550713e-01 | 0.809 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.102381e-01 | 0.958 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.723438e-01 | 0.764 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.749983e-01 | 0.757 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.749983e-01 | 0.757 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 1.749983e-01 | 0.757 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.761366e-01 | 0.754 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.761366e-01 | 0.754 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 1.761366e-01 | 0.754 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.824877e-01 | 0.739 | 1 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.837735e-01 | 0.736 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.837735e-01 | 0.736 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.837735e-01 | 0.736 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.837735e-01 | 0.736 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.837735e-01 | 0.736 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.837735e-01 | 0.736 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 1.837735e-01 | 0.736 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.837735e-01 | 0.736 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.840919e-01 | 0.735 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.860476e-01 | 0.730 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.875914e-01 | 0.727 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 1.914328e-01 | 0.718 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.924559e-01 | 0.716 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.924559e-01 | 0.716 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 1.924559e-01 | 0.716 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 1.924559e-01 | 0.716 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 1.924559e-01 | 0.716 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.924559e-01 | 0.716 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.924559e-01 | 0.716 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 1.924559e-01 | 0.716 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 1.924559e-01 | 0.716 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.952848e-01 | 0.709 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.989678e-01 | 0.701 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.991466e-01 | 0.701 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 2.010464e-01 | 0.697 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.010464e-01 | 0.697 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 2.010464e-01 | 0.697 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.010464e-01 | 0.697 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.030176e-01 | 0.692 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.030176e-01 | 0.692 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.030176e-01 | 0.692 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.038693e-01 | 0.691 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.068972e-01 | 0.684 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.068972e-01 | 0.684 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.077300e-01 | 0.683 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.095461e-01 | 0.679 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 2.095461e-01 | 0.679 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.095461e-01 | 0.679 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.095461e-01 | 0.679 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.095461e-01 | 0.679 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 2.121528e-01 | 0.673 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.146797e-01 | 0.668 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.150029e-01 | 0.668 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.179559e-01 | 0.662 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 2.179559e-01 | 0.662 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.179559e-01 | 0.662 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.179559e-01 | 0.662 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.179559e-01 | 0.662 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.179559e-01 | 0.662 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 2.179559e-01 | 0.662 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.185814e-01 | 0.660 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.224892e-01 | 0.653 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.224892e-01 | 0.653 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.224892e-01 | 0.653 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.250656e-01 | 0.648 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 2.250656e-01 | 0.648 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 2.250656e-01 | 0.648 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.262767e-01 | 0.645 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.262767e-01 | 0.645 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.262767e-01 | 0.645 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.262767e-01 | 0.645 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.262767e-01 | 0.645 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 2.262767e-01 | 0.645 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.262767e-01 | 0.645 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.264027e-01 | 0.645 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.264027e-01 | 0.645 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.306631e-01 | 0.637 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 2.342443e-01 | 0.630 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.342443e-01 | 0.630 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 2.342443e-01 | 0.630 | 1 | 1 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.345095e-01 | 0.630 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.345095e-01 | 0.630 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.345095e-01 | 0.630 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.345095e-01 | 0.630 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.345095e-01 | 0.630 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.345095e-01 | 0.630 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.345095e-01 | 0.630 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.421018e-01 | 0.616 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.421018e-01 | 0.616 | 1 | 1 |
| Signalling to RAS | R-HSA-167044 | 2.426552e-01 | 0.615 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 2.426552e-01 | 0.615 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.426552e-01 | 0.615 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.426552e-01 | 0.615 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.426552e-01 | 0.615 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.426552e-01 | 0.615 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.476040e-01 | 0.606 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.507147e-01 | 0.601 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 2.507147e-01 | 0.601 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 2.507147e-01 | 0.601 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.507147e-01 | 0.601 | 1 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.540630e-01 | 0.595 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.586890e-01 | 0.587 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 2.586890e-01 | 0.587 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 2.586890e-01 | 0.587 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 2.586890e-01 | 0.587 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 2.586890e-01 | 0.587 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.617886e-01 | 0.582 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.657294e-01 | 0.576 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.657294e-01 | 0.576 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.665789e-01 | 0.574 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.665789e-01 | 0.574 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 2.665789e-01 | 0.574 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 2.665789e-01 | 0.574 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.676007e-01 | 0.573 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.696703e-01 | 0.569 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.704740e-01 | 0.568 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.717287e-01 | 0.566 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.733340e-01 | 0.563 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 2.733507e-01 | 0.563 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.743852e-01 | 0.562 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.743852e-01 | 0.562 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.743852e-01 | 0.562 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.743852e-01 | 0.562 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 2.821090e-01 | 0.550 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 2.821090e-01 | 0.550 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 2.821090e-01 | 0.550 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.854259e-01 | 0.545 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 2.897510e-01 | 0.538 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.897510e-01 | 0.538 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 2.897510e-01 | 0.538 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.932930e-01 | 0.533 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.954085e-01 | 0.530 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 2.954085e-01 | 0.530 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.964685e-01 | 0.528 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.972225e-01 | 0.527 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 2.972225e-01 | 0.527 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.973122e-01 | 0.527 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.973122e-01 | 0.527 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 2.973122e-01 | 0.527 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.973122e-01 | 0.527 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.973122e-01 | 0.527 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.973122e-01 | 0.527 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 2.973122e-01 | 0.527 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.973122e-01 | 0.527 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.973122e-01 | 0.527 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 3.011488e-01 | 0.521 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.047933e-01 | 0.516 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.047933e-01 | 0.516 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.047933e-01 | 0.516 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.047933e-01 | 0.516 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 3.047933e-01 | 0.516 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 3.047933e-01 | 0.516 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.121952e-01 | 0.506 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.121952e-01 | 0.506 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.121952e-01 | 0.506 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.121952e-01 | 0.506 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 3.121952e-01 | 0.506 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.121952e-01 | 0.506 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.121952e-01 | 0.506 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.121952e-01 | 0.506 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.129047e-01 | 0.505 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.168144e-01 | 0.499 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.186346e-01 | 0.497 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.195188e-01 | 0.496 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.195188e-01 | 0.496 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.195188e-01 | 0.496 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.207192e-01 | 0.494 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 3.246186e-01 | 0.489 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.265586e-01 | 0.486 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 3.267648e-01 | 0.486 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.267648e-01 | 0.486 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.267648e-01 | 0.486 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.267648e-01 | 0.486 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.285123e-01 | 0.483 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.324001e-01 | 0.478 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.339342e-01 | 0.476 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.339342e-01 | 0.476 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.339342e-01 | 0.476 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.401564e-01 | 0.468 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.401564e-01 | 0.468 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.410276e-01 | 0.467 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.410276e-01 | 0.467 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.478851e-01 | 0.459 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.480459e-01 | 0.458 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.480459e-01 | 0.458 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 3.480459e-01 | 0.458 | 0 | 0 |
| Translation | R-HSA-72766 | 3.496449e-01 | 0.456 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.549899e-01 | 0.450 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.549899e-01 | 0.450 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 3.549899e-01 | 0.450 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.618603e-01 | 0.441 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.618603e-01 | 0.441 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.670714e-01 | 0.435 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.670714e-01 | 0.435 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.686580e-01 | 0.433 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.686580e-01 | 0.433 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.686580e-01 | 0.433 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.686580e-01 | 0.433 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 3.686580e-01 | 0.433 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.686580e-01 | 0.433 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.686580e-01 | 0.433 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.746862e-01 | 0.426 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.746862e-01 | 0.426 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 3.753837e-01 | 0.426 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.753837e-01 | 0.426 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.753837e-01 | 0.426 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.753837e-01 | 0.426 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.820382e-01 | 0.418 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 3.822639e-01 | 0.418 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.886222e-01 | 0.410 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.886222e-01 | 0.410 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 3.886222e-01 | 0.410 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.951364e-01 | 0.403 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.951364e-01 | 0.403 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.951364e-01 | 0.403 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 3.951364e-01 | 0.403 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.951364e-01 | 0.403 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.973009e-01 | 0.401 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 4.010342e-01 | 0.397 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 4.012769e-01 | 0.397 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 4.012769e-01 | 0.397 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.015816e-01 | 0.396 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.047567e-01 | 0.393 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.047567e-01 | 0.393 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.079586e-01 | 0.389 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.079586e-01 | 0.389 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.079586e-01 | 0.389 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.142679e-01 | 0.383 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.180307e-01 | 0.379 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.195354e-01 | 0.377 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 4.205105e-01 | 0.376 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.232013e-01 | 0.373 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.234332e-01 | 0.373 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 4.266868e-01 | 0.370 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 4.266868e-01 | 0.370 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 4.266868e-01 | 0.370 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.266868e-01 | 0.370 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 4.327978e-01 | 0.364 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.327978e-01 | 0.364 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 4.341271e-01 | 0.362 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.388439e-01 | 0.358 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.413497e-01 | 0.355 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.448260e-01 | 0.352 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.507447e-01 | 0.346 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.514362e-01 | 0.345 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.542072e-01 | 0.343 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 4.623945e-01 | 0.335 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.623945e-01 | 0.335 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.662241e-01 | 0.331 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.679746e-01 | 0.330 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.737986e-01 | 0.324 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.737986e-01 | 0.324 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.737986e-01 | 0.324 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 4.758645e-01 | 0.323 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.794102e-01 | 0.319 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 4.904554e-01 | 0.309 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.929085e-01 | 0.307 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 4.938403e-01 | 0.306 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.958903e-01 | 0.305 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.958903e-01 | 0.305 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.972290e-01 | 0.303 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.972290e-01 | 0.303 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 5.012676e-01 | 0.300 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.012676e-01 | 0.300 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.065879e-01 | 0.295 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 5.065879e-01 | 0.295 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 5.109472e-01 | 0.292 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 5.118517e-01 | 0.291 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 5.118517e-01 | 0.291 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 5.170597e-01 | 0.286 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 5.177569e-01 | 0.286 | 1 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.222124e-01 | 0.282 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.222124e-01 | 0.282 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.222124e-01 | 0.282 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.265930e-01 | 0.279 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.273105e-01 | 0.278 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.273105e-01 | 0.278 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.273105e-01 | 0.278 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.303134e-01 | 0.275 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.323545e-01 | 0.274 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 5.373450e-01 | 0.270 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.462963e-01 | 0.263 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.471677e-01 | 0.262 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.495394e-01 | 0.260 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.520010e-01 | 0.258 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 5.520010e-01 | 0.258 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.567830e-01 | 0.254 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 5.618985e-01 | 0.250 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.644730e-01 | 0.248 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.661954e-01 | 0.247 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 5.661954e-01 | 0.247 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.661954e-01 | 0.247 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.680318e-01 | 0.246 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.708267e-01 | 0.243 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 5.741035e-01 | 0.241 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.754089e-01 | 0.240 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 5.754089e-01 | 0.240 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.754089e-01 | 0.240 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.754089e-01 | 0.240 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.799425e-01 | 0.237 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 5.839135e-01 | 0.234 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.844280e-01 | 0.233 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.844280e-01 | 0.233 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 5.863050e-01 | 0.232 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.865951e-01 | 0.232 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.888658e-01 | 0.230 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 6.018985e-01 | 0.220 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 6.018985e-01 | 0.220 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 6.018985e-01 | 0.220 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.035321e-01 | 0.219 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.063895e-01 | 0.217 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.092315e-01 | 0.215 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.092315e-01 | 0.215 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.092315e-01 | 0.215 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 6.145204e-01 | 0.211 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 6.232086e-01 | 0.205 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.267444e-01 | 0.203 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 6.326421e-01 | 0.199 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.346789e-01 | 0.197 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.346789e-01 | 0.197 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.367990e-01 | 0.196 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.385830e-01 | 0.195 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.462672e-01 | 0.190 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.462672e-01 | 0.190 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.537889e-01 | 0.185 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.574900e-01 | 0.182 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.577452e-01 | 0.182 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 6.683587e-01 | 0.175 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.703425e-01 | 0.174 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 6.823187e-01 | 0.166 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 6.823187e-01 | 0.166 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 6.823187e-01 | 0.166 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 6.873493e-01 | 0.163 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 6.890780e-01 | 0.162 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.890780e-01 | 0.162 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.890780e-01 | 0.162 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.890780e-01 | 0.162 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 6.944160e-01 | 0.158 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.956944e-01 | 0.158 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 6.967423e-01 | 0.157 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.989499e-01 | 0.156 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 6.990485e-01 | 0.155 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.992493e-01 | 0.155 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 7.053573e-01 | 0.152 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.147152e-01 | 0.146 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.150216e-01 | 0.146 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.237775e-01 | 0.140 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.237775e-01 | 0.140 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 7.267342e-01 | 0.139 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.267342e-01 | 0.139 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 7.296594e-01 | 0.137 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.354168e-01 | 0.133 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.354168e-01 | 0.133 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.382496e-01 | 0.132 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.382496e-01 | 0.132 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.438251e-01 | 0.129 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 7.463233e-01 | 0.127 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.465684e-01 | 0.127 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 7.492825e-01 | 0.125 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 7.516415e-01 | 0.124 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.546243e-01 | 0.122 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.546243e-01 | 0.122 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.598530e-01 | 0.119 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.598530e-01 | 0.119 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.598530e-01 | 0.119 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 7.649708e-01 | 0.116 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.674890e-01 | 0.115 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.674890e-01 | 0.115 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.796828e-01 | 0.108 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.820442e-01 | 0.107 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.978840e-01 | 0.098 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 7.988387e-01 | 0.098 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 8.204938e-01 | 0.086 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 8.224200e-01 | 0.085 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 8.261202e-01 | 0.083 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 8.330416e-01 | 0.079 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 8.388571e-01 | 0.076 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.439927e-01 | 0.074 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.473256e-01 | 0.072 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.473256e-01 | 0.072 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.517932e-01 | 0.070 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 8.563825e-01 | 0.067 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.629580e-01 | 0.064 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.687557e-01 | 0.061 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.729433e-01 | 0.059 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.729433e-01 | 0.059 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.809242e-01 | 0.055 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 8.831066e-01 | 0.054 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.919705e-01 | 0.050 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.931331e-01 | 0.049 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 8.998974e-01 | 0.046 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.061514e-01 | 0.043 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.132674e-01 | 0.039 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.227809e-01 | 0.035 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.313698e-01 | 0.031 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.336596e-01 | 0.030 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.364778e-01 | 0.029 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.377776e-01 | 0.028 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.436289e-01 | 0.025 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.446229e-01 | 0.025 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.446229e-01 | 0.025 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.528250e-01 | 0.021 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.614718e-01 | 0.017 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.642100e-01 | 0.016 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.691692e-01 | 0.014 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.882862e-01 | 0.005 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.898637e-01 | 0.004 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.921952e-01 | 0.003 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.997712e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.110223e-16 | 15.955 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.110223e-16 | 15.955 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 9.880985e-15 | 14.005 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 9.880985e-15 | 14.005 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 2.253753e-14 | 13.647 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 6.272760e-14 | 13.203 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 6.272760e-14 | 13.203 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 7.804868e-14 | 13.108 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.179057e-13 | 12.928 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.538769e-13 | 12.813 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.671197e-13 | 12.573 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 2.838840e-13 | 12.547 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.343992e-13 | 12.476 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 3.745892e-13 | 12.426 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.923839e-13 | 12.308 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.918288e-13 | 12.308 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.119238e-13 | 12.291 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.384893e-13 | 12.195 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.384893e-13 | 12.195 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 7.537304e-13 | 12.123 | 1 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 9.152679e-13 | 12.038 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.059930e-12 | 11.975 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.133094e-12 | 11.946 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.353473e-12 | 11.869 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.365907e-12 | 11.865 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.353473e-12 | 11.869 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.718292e-12 | 11.765 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.003508e-12 | 11.698 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.725709e-12 | 11.565 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.725709e-12 | 11.565 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.797540e-12 | 11.553 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 3.407052e-12 | 11.468 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 3.407052e-12 | 11.468 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.332112e-12 | 11.477 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.009437e-12 | 11.300 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 5.248357e-12 | 11.280 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 5.248357e-12 | 11.280 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 6.470602e-12 | 11.189 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 6.952439e-12 | 11.158 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 9.712786e-12 | 11.013 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 9.712786e-12 | 11.013 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 9.679035e-12 | 11.014 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 9.679035e-12 | 11.014 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.060885e-11 | 10.974 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.735123e-11 | 10.761 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.646983e-11 | 10.577 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.313638e-11 | 10.480 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 3.582568e-11 | 10.446 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.828327e-11 | 10.417 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.940914e-11 | 10.404 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.260647e-11 | 10.371 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 5.052114e-11 | 10.297 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.973488e-11 | 10.224 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.668888e-11 | 10.115 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 9.714440e-11 | 10.013 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.136514e-10 | 9.944 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.469961e-10 | 9.833 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.500653e-10 | 9.824 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.681758e-10 | 9.774 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.866873e-10 | 9.729 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.133153e-10 | 9.671 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.146620e-10 | 9.668 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.408117e-10 | 9.618 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.195394e-10 | 9.495 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.672546e-10 | 9.435 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.823520e-10 | 9.418 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.212700e-10 | 9.375 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.930953e-10 | 9.307 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.511722e-10 | 9.259 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.916653e-10 | 9.228 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 6.009794e-10 | 9.221 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.287277e-10 | 9.202 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 7.159330e-10 | 9.145 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.534765e-10 | 9.123 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.117074e-09 | 8.952 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.290300e-09 | 8.889 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.275494e-09 | 8.894 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.183659e-09 | 8.927 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.507556e-09 | 8.822 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.562909e-09 | 8.806 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.767774e-09 | 8.753 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.908694e-09 | 8.719 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.104288e-09 | 8.677 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.143064e-09 | 8.669 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.315708e-09 | 8.635 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.029826e-09 | 8.519 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.720591e-09 | 8.429 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 5.161562e-09 | 8.287 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 6.155512e-09 | 8.211 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 6.352085e-09 | 8.197 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 6.961354e-09 | 8.157 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 7.034735e-09 | 8.153 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 8.235255e-09 | 8.084 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.156164e-08 | 7.937 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.213583e-08 | 7.916 | 1 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.475978e-08 | 7.831 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.188679e-08 | 7.660 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.188679e-08 | 7.660 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.188679e-08 | 7.660 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.243119e-08 | 7.649 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.377566e-08 | 7.624 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.677869e-08 | 7.572 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.143321e-08 | 7.503 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.143321e-08 | 7.503 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.441641e-08 | 7.463 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.894568e-08 | 7.310 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 4.894568e-08 | 7.310 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 4.894568e-08 | 7.310 | 0 | 0 |
| Disease | R-HSA-1643685 | 5.198526e-08 | 7.284 | 1 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 5.323224e-08 | 7.274 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.551087e-08 | 7.184 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.625771e-08 | 7.179 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 7.972286e-08 | 7.098 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 9.776924e-08 | 7.010 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.041695e-07 | 6.982 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.269802e-07 | 6.896 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.503662e-07 | 6.823 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.855011e-07 | 6.732 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.972647e-07 | 6.705 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.003946e-07 | 6.698 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.373171e-07 | 6.625 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.642619e-07 | 6.439 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.646072e-07 | 6.438 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.392064e-07 | 6.470 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.741427e-07 | 6.427 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.195465e-07 | 6.208 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.231906e-07 | 6.205 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 7.027538e-07 | 6.153 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 7.027538e-07 | 6.153 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 8.017984e-07 | 6.096 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.208613e-07 | 6.086 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 8.313053e-07 | 6.080 | 1 | 1 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.364605e-07 | 6.078 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 9.543379e-07 | 6.020 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.012760e-06 | 5.994 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.109021e-06 | 5.955 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.161715e-06 | 5.935 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.341108e-06 | 5.873 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.421794e-06 | 5.847 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.717127e-06 | 5.765 | 1 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.854946e-06 | 5.732 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.217285e-06 | 5.654 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.023342e-06 | 5.694 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.217285e-06 | 5.654 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.899508e-06 | 5.721 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.971009e-06 | 5.705 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.217285e-06 | 5.654 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.304304e-06 | 5.637 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.304304e-06 | 5.637 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.146900e-06 | 5.502 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.274225e-06 | 5.485 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.879487e-06 | 5.411 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 4.056625e-06 | 5.392 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.686696e-06 | 5.329 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 7.948369e-06 | 5.100 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 8.922783e-06 | 5.049 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 9.287367e-06 | 5.032 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 9.843048e-06 | 5.007 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.843048e-06 | 5.007 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 9.922486e-06 | 5.003 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.059140e-05 | 4.975 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.190236e-05 | 4.924 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.232289e-05 | 4.909 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.448319e-05 | 4.839 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.938707e-05 | 4.712 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.938707e-05 | 4.712 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.938707e-05 | 4.712 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.938707e-05 | 4.712 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.064572e-05 | 4.685 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.212714e-05 | 4.655 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.443424e-05 | 4.612 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.842498e-05 | 4.546 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.274070e-05 | 4.485 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.054174e-05 | 4.392 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.635804e-05 | 4.249 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 5.005264e-05 | 4.301 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.953285e-05 | 4.305 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 6.325685e-05 | 4.199 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 6.411956e-05 | 4.193 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 6.716765e-05 | 4.173 | 1 | 0 |
| HSF1 activation | R-HSA-3371511 | 7.899825e-05 | 4.102 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 8.602582e-05 | 4.065 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 8.655261e-05 | 4.063 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 8.722827e-05 | 4.059 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.791907e-05 | 4.056 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.013888e-04 | 3.994 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.013888e-04 | 3.994 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.225823e-04 | 3.912 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.234729e-04 | 3.908 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.312201e-04 | 3.882 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.315863e-04 | 3.881 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.376126e-04 | 3.861 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.447214e-04 | 3.839 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.447214e-04 | 3.839 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.447214e-04 | 3.839 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.575549e-04 | 3.803 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.583618e-04 | 3.800 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 2.216063e-04 | 3.654 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.324076e-04 | 3.634 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.458487e-04 | 3.609 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.458487e-04 | 3.609 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.668993e-04 | 3.574 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.754889e-04 | 3.560 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 3.206027e-04 | 3.494 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.240666e-04 | 3.489 | 1 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.363871e-04 | 3.473 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.595244e-04 | 3.444 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.685671e-04 | 3.433 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.877891e-04 | 3.411 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 4.479996e-04 | 3.349 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.233476e-04 | 3.373 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.883764e-04 | 3.311 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.606521e-04 | 3.251 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.446871e-04 | 3.352 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 4.352101e-04 | 3.361 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.446871e-04 | 3.352 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 4.352101e-04 | 3.361 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 4.593961e-04 | 3.338 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.616174e-04 | 3.336 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 5.848323e-04 | 3.233 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.848323e-04 | 3.233 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.848323e-04 | 3.233 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 5.964752e-04 | 3.224 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.083402e-04 | 3.216 | 0 | 0 |
| Kinesins | R-HSA-983189 | 6.406786e-04 | 3.193 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 6.470738e-04 | 3.189 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.665851e-04 | 3.176 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 6.964113e-04 | 3.157 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.607390e-04 | 3.119 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.633818e-04 | 3.117 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.654715e-04 | 3.116 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 7.832136e-04 | 3.106 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.056811e-04 | 3.094 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.207023e-04 | 3.086 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 9.142760e-04 | 3.039 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 9.582514e-04 | 3.019 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.926948e-04 | 3.003 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.008939e-03 | 2.996 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.135923e-03 | 2.945 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.242948e-03 | 2.906 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.275211e-03 | 2.894 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.415697e-03 | 2.849 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.425863e-03 | 2.846 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.651273e-03 | 2.782 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.682482e-03 | 2.774 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.754341e-03 | 2.756 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.888554e-03 | 2.724 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.933947e-03 | 2.714 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.090125e-03 | 2.680 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.304665e-03 | 2.637 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.449675e-03 | 2.611 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.460608e-03 | 2.609 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.500311e-03 | 2.602 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.522894e-03 | 2.598 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.640822e-03 | 2.578 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.078180e-03 | 2.512 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.196022e-03 | 2.495 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.377054e-03 | 2.471 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.483648e-03 | 2.458 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.746971e-03 | 2.426 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.816134e-03 | 2.418 | 1 | 1 |
| Gene expression (Transcription) | R-HSA-74160 | 3.996402e-03 | 2.398 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.237747e-03 | 2.373 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.537545e-03 | 2.343 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.544459e-03 | 2.343 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.595952e-03 | 2.338 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 4.726631e-03 | 2.325 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.961535e-03 | 2.304 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.096865e-03 | 2.293 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 5.249894e-03 | 2.280 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.249894e-03 | 2.280 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.490579e-03 | 2.260 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 5.525139e-03 | 2.258 | 0 | 0 |
| Translation | R-HSA-72766 | 5.614232e-03 | 2.251 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.765123e-03 | 2.239 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.765123e-03 | 2.239 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 6.532884e-03 | 2.185 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.777573e-03 | 2.057 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.281472e-03 | 2.138 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 8.678234e-03 | 2.062 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.617562e-03 | 2.118 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.768664e-03 | 2.057 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 6.257537e-03 | 2.204 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 6.120763e-03 | 2.213 | 1 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 7.281472e-03 | 2.138 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 8.777573e-03 | 2.057 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 7.617562e-03 | 2.118 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 6.532884e-03 | 2.185 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 7.285817e-03 | 2.138 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.037961e-03 | 2.153 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.037961e-03 | 2.153 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 6.438256e-03 | 2.191 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 8.315077e-03 | 2.080 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.858663e-03 | 2.053 | 1 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.867237e-03 | 2.052 | 1 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.342797e-03 | 2.030 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.435330e-03 | 2.025 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.681886e-03 | 2.014 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.743309e-03 | 2.011 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.001134e-02 | 2.000 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.004810e-02 | 1.998 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.004810e-02 | 1.998 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.051640e-02 | 1.978 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.119469e-02 | 1.951 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.131731e-02 | 1.946 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.131731e-02 | 1.946 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.151260e-02 | 1.939 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.185562e-02 | 1.926 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.253857e-02 | 1.902 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.269395e-02 | 1.896 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.269395e-02 | 1.896 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.397096e-02 | 1.855 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.413976e-02 | 1.850 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.413976e-02 | 1.850 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.413976e-02 | 1.850 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.549260e-02 | 1.810 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.549260e-02 | 1.810 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.565325e-02 | 1.805 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.565325e-02 | 1.805 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.565325e-02 | 1.805 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.649895e-02 | 1.783 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.710408e-02 | 1.767 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.723296e-02 | 1.764 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.944647e-02 | 1.711 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.058530e-02 | 1.686 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.058530e-02 | 1.686 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.058530e-02 | 1.686 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.058530e-02 | 1.686 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.152841e-02 | 1.667 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.235511e-02 | 1.651 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.235511e-02 | 1.651 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.235511e-02 | 1.651 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.247149e-02 | 1.648 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 2.380147e-02 | 1.623 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.418551e-02 | 1.616 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.418551e-02 | 1.616 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 2.426218e-02 | 1.615 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.445526e-02 | 1.612 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.474931e-02 | 1.606 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.547022e-02 | 1.594 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.578689e-02 | 1.589 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.607515e-02 | 1.584 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.607515e-02 | 1.584 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.651993e-02 | 1.576 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.694974e-02 | 1.569 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.802268e-02 | 1.552 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.802268e-02 | 1.552 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 2.802268e-02 | 1.552 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.802268e-02 | 1.552 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.816255e-02 | 1.550 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.920094e-02 | 1.535 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 2.937093e-02 | 1.532 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 2.937093e-02 | 1.532 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 2.937093e-02 | 1.532 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 2.937093e-02 | 1.532 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.937093e-02 | 1.532 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.940082e-02 | 1.532 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.978666e-02 | 1.526 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 3.002679e-02 | 1.522 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.002679e-02 | 1.522 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.002679e-02 | 1.522 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.002679e-02 | 1.522 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 3.163482e-02 | 1.500 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 3.163482e-02 | 1.500 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.896945e-02 | 1.409 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.896945e-02 | 1.409 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.896945e-02 | 1.409 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.896945e-02 | 1.409 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.896945e-02 | 1.409 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.896945e-02 | 1.409 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.896945e-02 | 1.409 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.896945e-02 | 1.409 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.896945e-02 | 1.409 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.896945e-02 | 1.409 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.896945e-02 | 1.409 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.847365e-02 | 1.314 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.788443e-02 | 1.237 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.208619e-02 | 1.494 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.419961e-02 | 1.466 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 3.636578e-02 | 1.439 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 4.316861e-02 | 1.365 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.066668e-02 | 1.217 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.085149e-02 | 1.389 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 6.333572e-02 | 1.198 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 5.509828e-02 | 1.259 | 1 | 1 |
| Integrin signaling | R-HSA-354192 | 5.803782e-02 | 1.236 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.599658e-02 | 1.444 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.803782e-02 | 1.236 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 3.208619e-02 | 1.494 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.599658e-02 | 1.444 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.040291e-02 | 1.298 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.636578e-02 | 1.439 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.636578e-02 | 1.439 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.636578e-02 | 1.439 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.316861e-02 | 1.365 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.794547e-02 | 1.319 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.896945e-02 | 1.409 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 3.896945e-02 | 1.409 | 1 | 1 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.847365e-02 | 1.314 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 5.788443e-02 | 1.237 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.316861e-02 | 1.365 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.252764e-02 | 1.488 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 6.333572e-02 | 1.198 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.794547e-02 | 1.319 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.858348e-02 | 1.414 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.858348e-02 | 1.414 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.486230e-02 | 1.348 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.486230e-02 | 1.348 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 5.193570e-02 | 1.285 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 3.325604e-02 | 1.478 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 3.896945e-02 | 1.409 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 3.896945e-02 | 1.409 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.788443e-02 | 1.237 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 5.040291e-02 | 1.298 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.568081e-02 | 1.448 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.692653e-02 | 1.433 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.053704e-02 | 1.218 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 3.208619e-02 | 1.494 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.316861e-02 | 1.365 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.794547e-02 | 1.319 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.794547e-02 | 1.319 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 5.290485e-02 | 1.277 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.545018e-02 | 1.256 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.626092e-02 | 1.335 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.415974e-02 | 1.266 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.794547e-02 | 1.319 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.040291e-02 | 1.298 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.803782e-02 | 1.236 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.234472e-02 | 1.205 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.419961e-02 | 1.466 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 5.040291e-02 | 1.298 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.256353e-02 | 1.371 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.768096e-02 | 1.322 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 6.333572e-02 | 1.198 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.858348e-02 | 1.414 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.040291e-02 | 1.298 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 5.058484e-02 | 1.296 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 4.438740e-02 | 1.353 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 5.389583e-02 | 1.268 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.444463e-02 | 1.191 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 6.604389e-02 | 1.180 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 6.604389e-02 | 1.180 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 6.604389e-02 | 1.180 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 6.720272e-02 | 1.173 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 6.720272e-02 | 1.173 | 1 | 1 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 6.720272e-02 | 1.173 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 6.720272e-02 | 1.173 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 6.720272e-02 | 1.173 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 6.720272e-02 | 1.173 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 6.879016e-02 | 1.162 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 6.879016e-02 | 1.162 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.973842e-02 | 1.157 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 6.985078e-02 | 1.156 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 7.176959e-02 | 1.144 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 7.245190e-02 | 1.140 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 7.245190e-02 | 1.140 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 7.245190e-02 | 1.140 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.439303e-02 | 1.128 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 7.439303e-02 | 1.128 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 7.439303e-02 | 1.128 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 7.642941e-02 | 1.117 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 7.642941e-02 | 1.117 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 7.642941e-02 | 1.117 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 7.642941e-02 | 1.117 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 7.642941e-02 | 1.117 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 7.642941e-02 | 1.117 | 1 | 1 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 7.642941e-02 | 1.117 | 1 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 7.642941e-02 | 1.117 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 7.724765e-02 | 1.112 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.724765e-02 | 1.112 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 7.855428e-02 | 1.105 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.013645e-02 | 1.096 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.013645e-02 | 1.096 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.037347e-02 | 1.095 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.305847e-02 | 1.081 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.406647e-02 | 1.075 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 8.556540e-02 | 1.068 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 8.556540e-02 | 1.068 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 8.556540e-02 | 1.068 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 8.601280e-02 | 1.065 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.762261e-02 | 1.057 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.762261e-02 | 1.057 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 8.783110e-02 | 1.056 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.783110e-02 | 1.056 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.899851e-02 | 1.051 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 8.973982e-02 | 1.047 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.973982e-02 | 1.047 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.166591e-02 | 1.038 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.201470e-02 | 1.036 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.201470e-02 | 1.036 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 9.461158e-02 | 1.024 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 9.461158e-02 | 1.024 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 9.461158e-02 | 1.024 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 9.461158e-02 | 1.024 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.498896e-02 | 1.022 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.506050e-02 | 1.022 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 9.506050e-02 | 1.022 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 9.506050e-02 | 1.022 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 9.506050e-02 | 1.022 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 9.813502e-02 | 1.008 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.813502e-02 | 1.008 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 9.813502e-02 | 1.008 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.813502e-02 | 1.008 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.954531e-02 | 1.002 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.015502e-01 | 0.993 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.026387e-01 | 0.989 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.035688e-01 | 0.985 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.035688e-01 | 0.985 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.035688e-01 | 0.985 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 1.035688e-01 | 0.985 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.035688e-01 | 0.985 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.056188e-01 | 0.976 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.075225e-01 | 0.969 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.075225e-01 | 0.969 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.076769e-01 | 0.968 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.076769e-01 | 0.968 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.097507e-01 | 0.960 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.107035e-01 | 0.956 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.107035e-01 | 0.956 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.107035e-01 | 0.956 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.124380e-01 | 0.949 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.124380e-01 | 0.949 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.124380e-01 | 0.949 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.124380e-01 | 0.949 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.124380e-01 | 0.949 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 1.124380e-01 | 0.949 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.124380e-01 | 0.949 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.124380e-01 | 0.949 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 1.139091e-01 | 0.943 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 1.139445e-01 | 0.943 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.160640e-01 | 0.935 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.203908e-01 | 0.919 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.203908e-01 | 0.919 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 1.203908e-01 | 0.919 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.204224e-01 | 0.919 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.212200e-01 | 0.916 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.212200e-01 | 0.916 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.212200e-01 | 0.916 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.212200e-01 | 0.916 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.212200e-01 | 0.916 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 1.212200e-01 | 0.916 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.212200e-01 | 0.916 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 1.221017e-01 | 0.913 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.236655e-01 | 0.908 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.239234e-01 | 0.907 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 1.268807e-01 | 0.897 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.269617e-01 | 0.896 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.282924e-01 | 0.892 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.299156e-01 | 0.886 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.299156e-01 | 0.886 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 1.299156e-01 | 0.886 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.299156e-01 | 0.886 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.299156e-01 | 0.886 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.302786e-01 | 0.885 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.336155e-01 | 0.874 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.336155e-01 | 0.874 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.336155e-01 | 0.874 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.336155e-01 | 0.874 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.358917e-01 | 0.867 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.369718e-01 | 0.863 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.385257e-01 | 0.858 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 1.385257e-01 | 0.858 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.385257e-01 | 0.858 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.470511e-01 | 0.833 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.470511e-01 | 0.833 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.470511e-01 | 0.833 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.470511e-01 | 0.833 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.470511e-01 | 0.833 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.470511e-01 | 0.833 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.470511e-01 | 0.833 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.470511e-01 | 0.833 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 1.470511e-01 | 0.833 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.505763e-01 | 0.822 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.521234e-01 | 0.818 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 1.540189e-01 | 0.812 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.554927e-01 | 0.808 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 1.554927e-01 | 0.808 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.554927e-01 | 0.808 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.554927e-01 | 0.808 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.554927e-01 | 0.808 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.554927e-01 | 0.808 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.554927e-01 | 0.808 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.574769e-01 | 0.803 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.574769e-01 | 0.803 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.574769e-01 | 0.803 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.638512e-01 | 0.786 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.638512e-01 | 0.786 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.638512e-01 | 0.786 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.709308e-01 | 0.767 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.714489e-01 | 0.766 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.721275e-01 | 0.764 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.721275e-01 | 0.764 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.721275e-01 | 0.764 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.721275e-01 | 0.764 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 1.721275e-01 | 0.764 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 1.721275e-01 | 0.764 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.749740e-01 | 0.757 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.785107e-01 | 0.748 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.803224e-01 | 0.744 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.803224e-01 | 0.744 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.803224e-01 | 0.744 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.803224e-01 | 0.744 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.803224e-01 | 0.744 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.820585e-01 | 0.740 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.820585e-01 | 0.740 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 1.856168e-01 | 0.731 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 1.856168e-01 | 0.731 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.884367e-01 | 0.725 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 1.884367e-01 | 0.725 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.884367e-01 | 0.725 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.891851e-01 | 0.723 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.927629e-01 | 0.715 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 1.927629e-01 | 0.715 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.956615e-01 | 0.708 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.964712e-01 | 0.707 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 1.964712e-01 | 0.707 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.035474e-01 | 0.691 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.044266e-01 | 0.689 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.044266e-01 | 0.689 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.044266e-01 | 0.689 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.107747e-01 | 0.676 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.123038e-01 | 0.673 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.123038e-01 | 0.673 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.123038e-01 | 0.673 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.123038e-01 | 0.673 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.160408e-01 | 0.665 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.180276e-01 | 0.661 | 1 | 1 |
| Signaling by MET | R-HSA-6806834 | 2.180276e-01 | 0.661 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.180276e-01 | 0.661 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 2.201034e-01 | 0.657 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.201034e-01 | 0.657 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.278263e-01 | 0.642 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.278263e-01 | 0.642 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.278263e-01 | 0.642 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.354732e-01 | 0.628 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.354732e-01 | 0.628 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.354732e-01 | 0.628 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.354732e-01 | 0.628 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.354732e-01 | 0.628 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.354732e-01 | 0.628 | 1 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.362472e-01 | 0.627 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.394704e-01 | 0.621 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.399025e-01 | 0.620 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 2.421012e-01 | 0.616 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.424083e-01 | 0.615 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.430448e-01 | 0.614 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.435607e-01 | 0.613 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 2.472212e-01 | 0.607 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 2.505419e-01 | 0.601 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 2.505419e-01 | 0.601 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.505419e-01 | 0.601 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 2.531483e-01 | 0.597 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 2.553243e-01 | 0.593 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 2.579652e-01 | 0.588 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 2.579652e-01 | 0.588 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.653154e-01 | 0.576 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 2.653154e-01 | 0.576 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 2.653154e-01 | 0.576 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 2.653154e-01 | 0.576 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.655462e-01 | 0.576 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 2.713223e-01 | 0.567 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 2.725933e-01 | 0.564 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 2.725933e-01 | 0.564 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 2.765454e-01 | 0.558 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 2.789389e-01 | 0.554 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.797995e-01 | 0.553 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.797995e-01 | 0.553 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.797995e-01 | 0.553 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 2.802104e-01 | 0.553 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.869348e-01 | 0.542 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.869348e-01 | 0.542 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.869348e-01 | 0.542 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 2.869348e-01 | 0.542 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 2.869348e-01 | 0.542 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 2.869348e-01 | 0.542 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.911962e-01 | 0.536 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 2.928163e-01 | 0.533 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.939998e-01 | 0.532 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 2.939998e-01 | 0.532 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.948540e-01 | 0.530 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.009953e-01 | 0.521 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.009953e-01 | 0.521 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.079218e-01 | 0.512 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.079218e-01 | 0.512 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.079218e-01 | 0.512 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.079218e-01 | 0.512 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.147802e-01 | 0.502 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.215710e-01 | 0.493 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.215710e-01 | 0.493 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.215710e-01 | 0.493 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.215710e-01 | 0.493 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.215710e-01 | 0.493 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.282949e-01 | 0.484 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.282949e-01 | 0.484 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.282949e-01 | 0.484 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.312424e-01 | 0.480 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.349526e-01 | 0.475 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.349526e-01 | 0.475 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.349526e-01 | 0.475 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.394889e-01 | 0.469 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.415447e-01 | 0.467 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.415447e-01 | 0.467 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.415447e-01 | 0.467 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 3.415447e-01 | 0.467 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.415447e-01 | 0.467 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.420665e-01 | 0.466 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.480719e-01 | 0.458 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.480719e-01 | 0.458 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.480719e-01 | 0.458 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.480719e-01 | 0.458 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.480719e-01 | 0.458 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.545348e-01 | 0.450 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.545348e-01 | 0.450 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.545348e-01 | 0.450 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.545348e-01 | 0.450 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.545348e-01 | 0.450 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.588677e-01 | 0.445 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.609340e-01 | 0.443 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 3.670995e-01 | 0.435 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.672702e-01 | 0.435 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 3.672702e-01 | 0.435 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.672702e-01 | 0.435 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.672702e-01 | 0.435 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 3.672702e-01 | 0.435 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.672702e-01 | 0.435 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.735439e-01 | 0.428 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.735439e-01 | 0.428 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.735439e-01 | 0.428 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.735439e-01 | 0.428 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.735439e-01 | 0.428 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.735439e-01 | 0.428 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.741865e-01 | 0.427 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 3.792213e-01 | 0.421 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.797558e-01 | 0.420 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 3.797558e-01 | 0.420 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.797558e-01 | 0.420 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.812416e-01 | 0.419 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 3.859065e-01 | 0.414 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.859065e-01 | 0.414 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 3.859065e-01 | 0.414 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.859065e-01 | 0.414 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.859065e-01 | 0.414 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.919966e-01 | 0.407 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.919966e-01 | 0.407 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 3.919966e-01 | 0.407 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 3.919966e-01 | 0.407 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 3.929874e-01 | 0.406 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 3.980266e-01 | 0.400 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 3.980266e-01 | 0.400 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.980266e-01 | 0.400 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 4.039972e-01 | 0.394 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.039972e-01 | 0.394 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 4.091140e-01 | 0.388 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.099090e-01 | 0.387 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 4.099090e-01 | 0.387 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.099090e-01 | 0.387 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.099090e-01 | 0.387 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.099090e-01 | 0.387 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 4.099090e-01 | 0.387 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.157625e-01 | 0.381 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 4.157625e-01 | 0.381 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.157625e-01 | 0.381 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.157625e-01 | 0.381 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.157625e-01 | 0.381 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.157625e-01 | 0.381 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.215582e-01 | 0.375 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 4.272969e-01 | 0.369 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.272969e-01 | 0.369 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 4.296169e-01 | 0.367 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.329981e-01 | 0.364 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.386050e-01 | 0.358 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 4.441755e-01 | 0.352 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.441755e-01 | 0.352 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.441755e-01 | 0.352 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.441755e-01 | 0.352 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.452934e-01 | 0.351 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.496912e-01 | 0.347 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.496912e-01 | 0.347 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.496912e-01 | 0.347 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.551524e-01 | 0.342 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.551524e-01 | 0.342 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.551524e-01 | 0.342 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.596554e-01 | 0.338 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.712150e-01 | 0.327 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.712150e-01 | 0.327 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.727115e-01 | 0.325 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 4.834155e-01 | 0.316 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 4.868070e-01 | 0.313 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 4.919021e-01 | 0.308 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 4.919021e-01 | 0.308 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.919383e-01 | 0.308 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.969469e-01 | 0.304 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.969469e-01 | 0.304 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 4.969469e-01 | 0.304 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 4.982494e-01 | 0.303 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 5.045108e-01 | 0.297 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 5.068877e-01 | 0.295 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 5.101945e-01 | 0.292 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.117847e-01 | 0.291 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 5.117847e-01 | 0.291 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.117847e-01 | 0.291 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.117847e-01 | 0.291 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 5.128603e-01 | 0.290 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.166333e-01 | 0.287 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.199430e-01 | 0.284 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.261875e-01 | 0.279 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.290486e-01 | 0.277 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.308939e-01 | 0.275 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.401679e-01 | 0.267 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.447364e-01 | 0.264 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.492597e-01 | 0.260 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.537384e-01 | 0.257 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.581729e-01 | 0.253 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.581729e-01 | 0.253 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 5.699821e-01 | 0.244 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 5.699821e-01 | 0.244 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 5.754770e-01 | 0.240 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.754770e-01 | 0.240 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 5.754770e-01 | 0.240 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.754770e-01 | 0.240 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.880116e-01 | 0.231 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.921075e-01 | 0.228 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 5.961630e-01 | 0.225 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.001783e-01 | 0.222 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.080904e-01 | 0.216 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.080904e-01 | 0.216 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.080904e-01 | 0.216 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.234508e-01 | 0.205 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.271965e-01 | 0.203 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.309052e-01 | 0.200 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 6.382128e-01 | 0.195 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.523996e-01 | 0.185 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 6.558590e-01 | 0.183 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.592842e-01 | 0.181 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 6.626756e-01 | 0.179 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.626756e-01 | 0.179 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 6.693579e-01 | 0.174 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 6.693579e-01 | 0.174 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.726496e-01 | 0.172 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 6.791356e-01 | 0.168 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 6.860674e-01 | 0.164 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.886259e-01 | 0.162 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.978372e-01 | 0.156 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 6.978372e-01 | 0.156 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 6.999113e-01 | 0.155 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.096989e-01 | 0.149 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.182905e-01 | 0.144 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.238774e-01 | 0.140 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.293541e-01 | 0.137 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 7.399859e-01 | 0.131 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.399859e-01 | 0.131 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.476863e-01 | 0.126 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.829183e-01 | 0.106 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 7.872305e-01 | 0.104 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.893545e-01 | 0.103 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 8.005164e-01 | 0.097 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.016633e-01 | 0.096 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 8.075470e-01 | 0.093 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.113727e-01 | 0.091 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.151229e-01 | 0.089 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.293969e-01 | 0.081 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 8.604693e-01 | 0.065 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.750897e-01 | 0.058 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 8.823411e-01 | 0.054 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 8.967569e-01 | 0.047 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.104255e-01 | 0.041 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.173715e-01 | 0.037 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.278903e-01 | 0.033 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.311043e-01 | 0.031 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.419827e-01 | 0.026 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.442834e-01 | 0.025 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.496461e-01 | 0.022 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.516446e-01 | 0.022 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 9.576111e-01 | 0.019 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.828434e-01 | 0.008 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.851257e-01 | 0.007 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.958362e-01 | 0.002 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.959076e-01 | 0.002 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.996011e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999961e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999974e-01 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
